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Abstract 
 
In Neurospora crassa, rhythmic conidiation is controlled by several oscillators such 
as FRQ/WCC and FLO. The frequency (frq) gene and white collar genes (WC-1 and 
WC-2) are the most important components of the FRQ/WCC oscillator and prd-1 and 
prd-2 genes could be important components of the FLO. This project aims to characterize 
the prd-1 mutation. This involved mapping the mutation using PCR analyses based on 
single nucleotide polymorphism (SNP) markers. After determining a minimal interval, 
candidate genes were sequenced, and knockout mutants were screened in this interval for 
prd-1 phenotype. A candidate gene was found to have a mutation that affects the splicing 
of the mRNA. The identity of the gene was confirmed by complementing the prd-1 
mutant with a wild type copy of the identified candidate gene. The prd-1 gene is 
identified as an RNA helicase.  
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1. Introduction 
1.1 Circadian rhythms 
The elements of temperature and light in our natural surroundings are inevitably 
altered by the earth rotating. Circadian is derived from the Latin word ‘circa’ which 
means about and ‘dies’ which means day. The evolution of circadian clocks is based on 
natural selection. Biological clocks are the endogenous cellular devices for measuring 
time. The clocks instil a benefit of survival by making it possible for a living being to 
anticipate the environmental changes that take place daily and therefore making its 
behaviour and physiology adapt to the daily changes at appropriate times. These clocks 
are synchronised by night-day cycles and enable a living form to synchronize with the 
daily light and dark cycles that are a result of the rotating earth (Panda et al. 2002). 
 Evolution created an accurate biological clock in many studied organisms. Studying 
and analysis of how such a precise biological clock is assembled and works have not been 
trivial tasks. Advanced development of genetic tools and the study of the genetics of 
circadian rhythms in model organisms like flies has opened up new avenues in the 
understanding of the daily regulation of circadian behaviours at the molecular level. 
Circadian rhythms are a fundamental property of living cells. All the organisms from 
unicells to humans show behavioural and physiological rhythms that continue with a 
period of approximately 24 h (Dunlap 1999). These rhythms are driven by biological 
clocks that have three important criteria.  
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First, the rhythms have a 24-hour period. Second, the free-running period of 24 h is 
temperature compensated, which means that clocks do not run slower at lower 
temperatures or speed up at higher temperature. Third, they can also be synchronised 
(entrained) by external stimuli such as light, temperature or feeding schedules (Takahashi 
et al. 2008).  
The importance of circadian clocks has been shown in prokaryotes and higher 
organisms (Woelfle et al. 2004, Dodd et al. 2005). Disruption of circadian rhythm in 
humans, as seen in rotational shift workers for example, causes important long-term 
health problems such as disorders of sleep, diabetes and obesity (Barger et al. 2009). In 
addition to sleep and feeding behaviour, the circadian clocks of animals also control 
rhythmicity in gene expression, cell cycle and metabolism, body temperature, hormone 
activity and blood pressure (de Paula et al., 2008). In plants, germination, flowering, 
fragrance emission and photosynthesis show circadian rhythms (McClung 2006). 
Observations of oscillatory systems date as far back as 1729 when de Marian 
described circadian rhythms in plant leaves (de Marian 1729). Initially he set out to 
investigate the leaf movements of Mimosa pudica in the dark in the absence of a stimulus 
and cyclic environmental information. He found that the leaf rhythm continued, therefore 
there should be an endogenous clock (Dunlap et al. 2004). In the 1970s,  the first 
mutation in Drosophila that disrupted the clock system was identified (Konopka et al. 
1971). Decades later in the 1990s, the first mammalian clock mutants where described 
(Vitatema et al. 1994). 
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The circadian clock contains three elements: the oscillator that has a positive and 
negative feedback loop, the input such as temperature or light that can reset the oscillator 
and the output pathways that regulate the observed rhythmicity.  
The proposed model for the oscillator is based on a transcription / translation 
feedback loop. In this loop transcription of clock genes is rhythmic and clock proteins 
feedback to regulate their own transcription negatively. To form a loop, rhythmic 
transcription leads to rhythmic levels of RNA and rhythmic mRNA levels cause rhythmic 
levels of proteins. The most important component for maintaining rhythmicity in 
organisms is rhythmic transcription of clock genes. In the transcription/translation 
oscillator (TTO) model Clock gene 2 is transcribed and translated into clock protein 2 
and this protein positively regulates the transcription of clock gene 1. On the other hand 
clock protein 1 negatively regulates its own transcription and inhibits the positive effect 
of clock protein 2. Clock protein 1 also positively regulates the transcription and 
translation of clock gene 2. (Fig.1.1) 
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Fig 1.1. Transcription/translation feedback oscillator (TTO) model for circadian 
rhythms. Two interlocked loops are interacting with each other. Clock protein 1 
positively regulates transcription of clock gene 2. Clock protein 2 positively regulates 
transcription of clock gene 1 (Lakin-Thomas, 2006 & de Paula et al. 2008). 
 
1.2. Molecular rhythms in Cyanobacteria 
The circadian rhythm in Cyanobacterium Synechococcus can be seen in the nitrogen 
fixation process. This process is regulated by the circadian clock to occur at night time 
because of the nitrogenase enzyme’s oxygen sensitivity. Therefore, photosynthesis which 
produces oxygen occurs in the day and nitrogen fixation happens at night.  
Essential clock genes in Cyanobacteria are kaiA, kaiB and kaiC that are found 
together in a cluster on the chromosome (Ishiura et al. 1998). Further studies of the 
kaiABC cluster suggested that the cynobacterial clockwork is similar to the mechanism 
that was proposed for the circadian system in eukaryotes, which is a 
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transcription/translation feedback loop (Hardin et al. 1990, Dunlap 1999) (Fig.1.2). The 
level of kaiB and kaiC mRNA and protein oscillate and overexpression of KaiC protein 
can repress the kaiC gene and reset the clock (Xu et al. 2000, Ishiura et al. 1998). It was 
also shown that KaiC can be phosphorylated rhythmically (Iwasaki et al. 2002). Deletion 
of any of these kai genes can abolish the rhythm and mutation in kaiC, kaiB or kaiA can 
change the period. kaiC has autophosphorylation and autodephosphorylation activity and 
it was shown that inhibition of a kai gene does not require a kai specific promoter (Ditty 
et al. 2003, Xu et al. 2003, Nakahira et al. 2004). Experiments from the Kondo team 
demonstrated reconstitution of the KaiC rhythm in vitro by mixing purified KaiA, KaiB 
and KaiC and also ATP in a test tube. It was found that KaiA promotes 
autophosphorylation of KaiC, however KaiB hinders the positive effect of KaiA and 
interaction between these three Kai proteins can create the oscillation of KaiC 
phosphorylation. 
It was shown that oscillation in KaiC phosphorylation is the molecular time keeper in 
Synechoccus (Nakajima et al. 2005). Therefore, the underlying mechanism for 
Cyanobacteria is based on a post-translational oscillator (PTO) and also a 
transcriptional/translational feedback loop (TTFL). In the absence of KaiC 
phosphorylation the gene expression rhythmicity is gone so the KaiC oscillation is the 
master pacemaker in Cyanobacteria. Interaction of the TTFL and the protein oscillator 
can improve the robustness of the circadian clock (Johnson et al. 2008).   
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Fig 1.2. Proposed model for circadian system in Cyanobacteria (red loop). KaiC 
negatively regulates its own (kaiBC) expression to generate a molecular feedback loop, 
whereas KaiA activates kaiBC expression as a positive element to make the loop 
oscillate. Furthermore, posttranslational events like protein-protein interactions and 
phosphorylation may be required for regulation of their functions. SasA which is a KaiC-
interacting sensory histidine kinase improves expression of kaiBC genes. SasA also likely 
adjusts sensitivity of robustness of the oscillator to light. CikA is a phytochrome-related 
histidine kinase that would be a circadian photoreceptor. The CR-1 and PEX proteins 
may also associate with some circadian photoreceptive pathways, while CpmA and 
RpoD2 are components of output pathways (Iwasaki and Kondo 2000). 
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1.3. Molecular rhythms in Drosophila 
Eukaryotic systems share similar oscillators based on negative feedback loops that 
control the robust rhythm (Alabadi et al. 2001, Boxall et al. 2005). In addition to 
transcription-based interaction between clock components, post-transcriptional and post-
translational regulation coupled with chromatin modifications are involved in regulating 
and controlling the oscillators (Covington et al. 2001, Daniel et al. 2004). 
In the fruit fly Drosophila melanogaster lateral neurons (LNs) located in the central 
brain are considered as the central circadian pacemaker. LNs are able to control the rest, 
activity rhythms and timing of eclosion. 
Molecular and genetic studies in Drosophila have revealed that the circadian rhythm 
mechanism is based on a TTO (Fig.1.3). The first known clock gene in Drosophila was 
the period (per) (Konopka et al. 1971) gene. Later, by identifying the other genes 
involved in this autoregulatry feedback loop, it was proposed that there are two 
interlocked feedback loops in Drosophila.  Gene expression in the period/timeless 
(per/tim) and Clock (Clk) feedback loops is regulated primarily at the transcriptional and 
post-translational levels (Allada et al. 2003, Glossop et al. 1999, Young et al.2001). 
Because of this post-translational regulation, delays in abundance and activity of 
transcriptional inhibitors and activators can be seen. This delay regulates the timing of 
clock gene transcription during the circadian cycle.  
For the circadian oscillator to function normally, it needs both types of regulation, 
transcriptional and post-translational. It was shown that in the absence of DOUBLETIME 
(DBT) kinase activity, or by altering the phosphorylation site of PER, the circadian 
period can be changed considerably and by combining these two the oscillator function 
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will be eliminated (Chiu et al. 2008, Rothenfluh et al. 2000). This means post-
translational control is essential for rhythmicity. Similarly, circadian oscillator function is 
diminished or abolished by eliminating per and tim mRNA cycling (Hall et al. 2007, 
Yang et al. 2001), showing that transcriptional control is also necessary. 
The feedback loops in Drosophila can be separated into different sequential phases 
including transcriptional activation, repression and reactivation. Hypophosphorylated 
CLOCK (CLK) makes a heterodimeric complex with CYCLE (CYC) and initiates the 
feedback loop. This complex binds to E-boxes and activates transcription of clock genes 
including period (per), timeless (tim), vrille (vri), PAR domain protein 1e (Pdp1e), and 
clockwork orange (cwo). A decrease in activation of CLK-CYC-dependent transcription 
and consequently a long period of behavioral rhythm can be seen in cwo mutants and 
CWO knockdown strains (Kadener et al. 2007, Lim et al. 2007, Richier et al. 2008). It is 
not known how CWO affects the activation of CLK-CYC-dependent transcription but 
studies showed that CWO is one of the important components of the clock (McDonald et 
al. 2001, Lin et al. 2002). It was also determined that CWO competes with CLK-CYC to 
bind to E1 E-boxes and acts to repress CLK–CYC transcription (Kadener et al. 2007).  
During the night, PER accumulates to high levels. TIM is needed for PER accumulation 
(Price et al. 1995) but it is not essential for repression. Therefore, a complex of PER and 
DOUBLETIME kinase (DBT) is sufficient to mediate repression (Chang et al. 2003). A 
complex of PER-DBT can interact with CLK-CYC, and PER-CLK binding is required 
for this repression by mediating hyperphosphorylation of CLK. This suggests that CLK 
hyperphophorylation can remove CLK-CYC from E-boxes to repress transcription (Kim 
et al. 2007). 
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At lights-on, transcriptional reactivation can be initiated when DBT- dependent 
phosphorylation encourages PER degradation (Nawathean et al. 2004). 
Hypophosphorylated CLK begins to accumulate and the next cycle of transcription will 
commence (Yu et al. 2006).  
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Fig 1.3.  Model for Drosophila TTO. In Drosophila a heterodimer of two PAS-
domain containing transcription factors dCLK/CYC binds to E-box of per/tim promoter 
and promotes their transcription. DBT phosphorylates cytoplasmic PER protein (P) and 
promotes its degradation. When TIM accumulates it can inhibit DBT activity and 
stabilize PER. Shaggy (S) phosphorylates TIM and causes the entry of PER/DBT/TIM 
into the nucleus. Later TIM is released from the complex and represses dCLK/CYC 
function. In the absence of TIM, PER is phosphorylated and degraded and dCLK/CYC is 
derepressed and a new cycle is starting. dCLK creates another feedback loop that inhibits 
its own transcription and PER promotes dCLK transcription (Adapted from Panda et al. 
2002). 
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1.4. Molecular circadian network in plants 
Circadian clocks in higher plants affect several regulatory pathways including 
metabolism, photosynthesis, hormone levels and growth regulation, nutrient uptake and 
flowering. Many studies were done to discover the transcription-based oscillator in 
Arabidopsis. 
In Arabidopsis, the core oscillator model (Fig.1.4) was based on three components 
and loss of function of any of these clock genes results in a short period clock. These 
components are two MYB domain-containing transcription factors CIRCADIAN 
CLOCK ASSOCIATED 1 (CCA1) and LATE ELONGATED HYPOCOTYL (LHY), 
and a member of the PSEUDO RESPONSE REGULATOR (PRR) family, TIMING OF 
CAB2 EXPRESSION 1 (TOC1) (Edwards et al. 2006). 
Several studies showed that TOC1 is a DNA-binding transcriptional repressor of 
CCA1 and LHY (Gendron et al. 2012). Along with CCA1 and LHY, TOC1 also binds the 
promoters and hinders the expression of the other oscillator components such as PRR5, 
PRR7, PRR9, LUX ARRHYTHMO (LUX), GIGANTEA (GI), and EARLY 
FLOWERING 4 (ELF4). In a morning-specific loop, CCA1 and LHY promote the 
expression of two TOC1 family members, PRR9 and PPR7, by directly binding to their 
promoters (Hanano et al. 2006, 2008). In return, PRR9, PRR7, and PRR5 function as 
transcriptional repressors to coregulate the expression of CCA1 and LHY. It was found 
that LIGHT-REGULATED WD1 (LWD1) contributes in a positive feedback loop with 
PRR9 and also indirectly increases expression of CCA1, LHY, PRR5 and TOC1. These 
results suggest that LWD1 functions as a transcriptional activator. It is known that in 
eukaryotic cells, post-translational regulation participates in keeping robust circadian 
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rhythms (McWatters et al. 2000, 2007). For instance, Casein Kinase 2 (CK2) is one of the 
conserved components in mammals, Drosophila, Neurospora and Arabidopsis that 
mediates regulation of clock genes (Michael et al. 2003, Millar et al. 1995). In 
Arabidopsis, CK2 phosphorylates CCA1 and LHY, and this process is considered to be 
important for CCA1 function. 
In Arabidopsis, it was known that hypocotyl growth can be regulated by circadian 
clocks as well as several external cues (Park et al. 1999). Two key clock-related 
components in hypocotyl growth in Arabidopsis are PIF4 and PIF5. LUX which is one 
component of the evening complex (LUX, ELF3 and ELF4) binds to PIF4 and PIF5 
promoters and represses them (Park et al. 1999, Kevei et al. 2006). Therefore hypocotyl 
growth is inhibited in early evenings and later on when the repression is released 
hypocotyl growth occurs. 
Further studies demonstrated that molecular clock interactions can regulate the 
photoperiodic flowering. The known components that connect circadian oscillator to 
photoperiodic flowering are GIGANTEA (GI), flowering regulators CONSTANS (CO) 
and FLOWERING LOCUS T (FT) (Roenneberg et al. 1993, Sai et al. 1999). 
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Fig 1.4. Model proposed for the plant clock. Loop A is the first identified feedback 
loop that consists of CCA1 and LHY that negatively regulate expression of TOC1. TOC1 
can directly or indirectly activate the expression of CCA1 and LHY. Loop B is composed 
of two or more evening phase genes and loop C consists of morning phase genes like 
PRR7, PRR9, CCA1 and LHY. In loop D ZTL negatively regulate TOC1 protein 
abundance and its activity is regulated by PRR3 and GI (Harmer  2009). 
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1.5. Circadian rhythms in mammals 
In mammalian cells, like other organisms, circadian clocks are driven based on 
autoregulatory negative-feedback transcriptional loops (Lowrey & Takahashi 
2004,Takahashi et al. 2008). The core components of this network are CLOCK and 
BMAL1 which positively regulate the expression of Period (Per1 and Per2) and 
Cryptochrome (Cry1 and Cry2). Per and Cry proteins form a complex and after 
translocation into the nucleus they interact with CLOCK and BMAL1 and repress their 
own transcription. Another candidate gene that plays a role in the circadian gene network 
is Rev-erbα (Fig.1.5). 
The hypothalamic suprachiasmatic nucleus (SCN) was identified as the main 
circadian pacemaker for generation of circadian behavioral rhythms in mammals (Welsh 
et al. 2010). After the discovery of clock genes and by using gene reporter methods it was 
found that most peripheral organs and tissues can express circadian oscillations and this 
circadian expression is extensive throughout the body (Dibner et al. 2010). In order to 
have an accurate circadian system, the SCN controls the peripheral oscillators and loss of 
SCN can cause desynchronization of peripheral circadian clocks (Yoo et al. 2004). 
Therefore, tissue specific gene expressions are regulated by both “local” as well as 
central mechanisms. The SCN receives the input from retina photoreceptor cells called 
intrinsically photosensitive Retinal Ganglion Cells (ipRGC). In addition to ipRGC that 
seem to be important circadian photoreceptors, rod and cone photoreceptors also 
participate to provide photic inputs to SCN (Chen et al. 2011, Guler et al. 2008). 
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For many years it has been known that there is a relationship between the cell cycle 
and the clock work. DNA synthesis and replication are performed at night; therefore they 
are not exposed to harmful UV radiation. Clock components per-1 and per-2 are 
recognized as tumour suppressors and any defects in these genes can result in tumour 
formation in vivo. On the other hand cryptochrome (cry) is an oncogene and loss of cry 
can decrease the risk of cancer in p53 mutant mice (Yi et al. 2010). BMAL/CLOCK 
complexes can control the expression of cell cycle and cell proliferation genes such as c-
Myc and wee1 (Reddy et al. 2005). 
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Fig 1.5. Proposed model for the circadian system in mammalian cells. In the nucleus 
the Clock/Bmal1 dimer binds to a E-box of several genes to activate their expressions 
such as Per1, Per2, Cry1, and Cry2. The Per/Cry protein dimers are phosphorylated in the 
cytoplasm by kinases such as casein kinase Iε /δ (CKIε /δ). Then the Per/Cry dimers 
translocate to the nucleus in a phosphorylation-regulated manner where they interact with 
the Clock/Bmal1 complex to repress their own activators. In addition to this core 
transcriptional feedback loop, there are other feedback loops involving Rev-erbα and 
Rorα that repress Bmal1 transcription. CLOCK/BMAL1 also regulates many downstream 
target genes known as clock-controlled genes (ccgs) (Mohawk et al. 2012). 
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1.6. Circadian rhythms and human health 
Circadian variation can be observed in the human body. Circadian regulation can be 
seen in behavioral, neural, physiological and endocrine functions. Blood pressure, body 
temperature, respiration, awake-sleep cycles and hormone levels (cortisol and melatonin) 
are some of the circadian rhythms that are manifest through numerous physiological 
actions. These circadian rhythms have an impact on the health of a person (Levi et al. 
2007, Hu et al. 2008). 
Jet lag is a common effect of these rhythms and is a result of the variance between the 
genetic and the environment time. Stroke, sudden cardiac arrest that leads to death, 
cardiac arrhythmia and severe myocardial infarction are all cardiovascular illnesses that 
are linked to circadian rhythms and they mostly take place in the morning but rarely they 
happen during sleep time.  Shift-work is another example whereby the chance of 
cardiovascular related deaths and cancer cases in human and hamsters is significantly 
increased by the desynchronization of the circadian clock with environmental shifting 
(Penev et al. 1998). Diseases such as ischaemic stroke, that shares risk factors with 
cardiovascular disease, are known to happen more in long-term female shift workers 
(Brown et al. 2009). There is also a correlation between breast cancer risk and long-term 
shift working (Schernhammer et al. 2001, 2006).  
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1.7. Neurospora 
Neurospora is a filamentous fungus, a heterothallic species that produces numerous 
nuclei in distinct hyphae. It has two unique cycles in its life, the diploid sexual cycle and 
the haploid asexual cycle. In the asexual part of the cycle, the macroconidia germinate in 
favourable growth conditions to create the first germ tube. It later continues to develop by 
the tip extending and branching out to produce the threads of hyphae that do not have any 
cross walls and contain many haploid nuclei. A colony is able to generate millions of 
multinucleate conidia from aerial hyphae, and dispersal of these conidia can repeat the 
asexual cycle if they are located in suitable conditions (Davis, 2000). 
The two mating types are determined by alternative DNA sequences at one 
chromosomal locus; these are called MAT A and MAT a. When colonies of different 
mating type come into contact, the sexual phase occurs. After fusion of cell walls and 
nuclei a diploid nucleus forms in a fruiting body called perithecia. These diploid nuclei 
undergo meiosis and four haploid nuclei are generated and they undergo mitosis and 
make eight ascospores that are placed in an ascus. Ascospores germinate and produce 
hyphae resulting in colonies exactly like those produced by asexual spores (Davis, 2000). 
Neurospora is one of the best-studied microorganisms in circadian biology. Because 
it is a haploid organism, it is easy to isolate new mutations. The genome has been 
sequenced (Galagan et al. 2003), and annotation can be found online at Broad Institute 
Database (http://www.broadinstitute.org). Knockout strains can be generated (Colot et al. 
2006), and they are available from the Fungal Genetic Stock Center (www.fgsc.net). 
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After Drosophila, which was the first organism in which a circadian clock mutation 
was identified (Konopka and Benzer, 1971), Neurospora was the second organism 
(Feldman and Hoyle, 1973). The circadian output in Neurospora can be observed as 
rhythmic conidia formation that can be visually seen as bands of conidia and interbands. 
The first identified clock gene in Neurospora was frequency (frq). There are seven frq 
mutations that influence the rhythm in Neurospora which are frq1, frq2, frq3, frq7, frq9, 
frq10 and frq11. When strains are carrying these mutations, the period is changed or they 
are arrhythmic or have no temperature compensation (Morgan et al. 2001). There are 
many other clock-affecting mutations that are involved in the clock or can affect the 
clocks such as period (prd-1, prd-2, prd-3, prd-4 and prd-6).  
1.8. Neurospora FRQ/WCC feedback loop 
Similar to the circadian oscillator in Drosophila and mammals, the core oscillator of 
Neurospora consists of a negative feedback loop (Aronson et al. 1994), in which FRQ 
(frequency), FRH (FRQ-interacting RNA helicase), WC-1 (white collar 1) and WC-2 are 
the main components (Fig.1.6). This oscillator is called the FRQ-WC oscillator (FWO). 
WC-1 and WC-2 are PAS (PER-ARNT-SIM) containing transcription factors that have 
GATA Zn finger DNA binding domains and are localized in the nucleus (Ballario et al. 
1996, Linden et al. 1997). A complex of FRQ and FRH is the negative element, and WC-
1 and WC-2 are positive elements (Aronson et al. 1994, Cheng et al. 2005). WC-1 and 
WC-2 form a heterodimeric complex (WCC) that binds to the Clock box (C box) in the 
frq promoter. After the FRQ protein is synthesized, it dimerizes with itself and forms a 
complex with FRH (Cheng et al. 2005, 2001). 
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The FRQ-FRH complex (FFC) inhibits WC complex activity by interacting with the 
WC proteins. FRQ stability is important for period length. When FRQ is synthesized it is 
progressively phosphorylated by kinases like CKI and CKII and when it is 
hyperphosphorylated it goes through the ubiquitination pathway and degradation. When 
the level of FRQ is low, WCC is no longer inhibited by FRQ-FRH complex and a new 
cycle starts (Liu et al. 2006). Therefore, three essential phases in the circadian rhythm in 
Neurospora are activation of frq transcription by WCC, inhibition of WCC by FFC and 
degradation and phosphorylation of FRQ. 
In Neurospora, light acts rapidly through the WCC to induce high levels of frq 
expression. Light induction of frq requires two cis-acting elements (LREs) in the frq 
promoter.  The LREs are bound by a WC-1/WC-2 complex (WCC), and light causes 
WCC to bind to the LREs. WC-1 is the blue light photoreceptor that with its cofactor 
FAD (flavin adenine dinucleotide) and WC-2 mediates light input to the circadian system 
(Dunlap et al. 2004). 
There are some highly conserved components from Neurospora to mammals that are 
essential for post-translational regulation. Phosphorylation of FRQ and PER (although 
they are not homologs) occurs with kinases CKI and CKII and they are dephosphorylated 
by phosphatases PP2A (Akten et al. 2003, Gorl et al. 2001, Kloss et al. 1998). 
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Fig 1.6. FRQ/WCC negative feedback oscillator in Neurospora (Liu & Bell-
Pederson, 2006) 
 
1.9. FRQ-less oscillator 
Numerous studies demonstrated that rhythmic conidiation can be seen in the absence 
of clock gene function. The first report of rhythmicity in frq and wc null strains was 
observed when they were grown in extra-long race tubes (Aronson et al. 1994; Loros and 
Feldman, 1986). This means that in addition to the FRQ-based oscillator, there may be 
one or more FRQ-less oscillators that are involved in driving rhythmic conidiation 
(Froehlich et al. 2003; de Paula et al. 2006). The FRQ-less oscillator (FLO) does not have 
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circadian properties including temperature compensation and light entrainment and it also 
shows more variable periods compared to wild type (Dunlap and Loros, 2004). 
The presence of a FLO (or FLOs) was also suggested by finding that frq, wc-1 and 
wc-2 null mutants that are arrhythmic in standard conditions, showed rhythmicity when 
they are grown on media enriched with farnesol or geraniol (Granshaw et al. 2003). 
Rhythmicity was restored when double mutants are constructed of clock genes with 
mutations that affect lipid synthesis like cel or chol mutations (Lakin-Thomas and Brody 
2000). The chol-1 (choline) mutation has effects on lipid synthesis and the cho-1 mutant 
needs choline supplement for normal growth. Choline depletion inhibits growth and 
lengthens the period and also abolishes the temperature compensation of the conidiation 
rhythm (Lakin-Thomas, 1996, 1998).  
Mutations in clock genes can be separated into two groups: the ones that do not have 
any effect on rhythmicity in the absence of the FWO oscillator and the ones that do have 
an effect. The second group may be the genes that are involved in FLOs or can affect the 
interaction between FWO and FLOs. Some of these mutations that have clock effects in 
the absence of FWO, are ult (Lombardi et al. 2007), cel and chol (Lakin-Thomas and 
Brody 2000), UV90 and prd-1, prd-2 and prd-6.  
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1.10. Effects of prd mutations 
The effects of prd-1, prd-2 and prd-6 on rhythmicity in the absence of a functional 
FWO indicates that they have effects on the function of FLO. Other prd mutations have 
been shown to have no effect. 
Previously it was shown that prd-1 mutants can change the fatty acid composition 
(Cote and Brody, 1987) and it is likely that has an effect on lipid oscillations. The prd-1 
rhythm phenotype of the mutant is a long period in frq+ strains (approximately 25.8 
hours) and also a long period of the FRQ-less rhythm with geraniol, and loss of the FRQ-
less rhythm in chol-1. Prd-1 also affects the FLO in cel (Lakin-Thomas and Brody 1985) 
and affects the heat entrainable FLO (Li and Lakin-Thomas 2010). The gene was not 
identified previously (Li and Lakin-Thomas 2010, Lombardi et al. 2007). It is described 
as a recessive mutation on chromosome III (Perkins et al. 2001). 
The prd-2 gene has not been identified yet but the prd-2 mutation has the effects of a 
long period of conidiation rhythm in frq+ strains, a long period of FRQ-less rhythms with 
geraniol, loss of the FRQ-less rhythm in chol-1, and severe effects on the heat-entrainable 
FRQ-less rhythm (Li and Lakin-Thomas, 2010, Lombardi et al. 2007). 
The prd-3 gene was identified as the catalytic subunit of casein kinase 2 (CKII).  
Effects of this mutation are a long period of the conidiation rhythm, altered temperature 
compensation, loss of FRQ protein rhythm, and RNA rhythms of frq, ccg-1, and ccg-2 
(Mehra et al. 2009), (Yang et al. 2002). 
The prd-4 gene was identified as checkpoint kinase 2 (CHK2). The prd-4 mutation 
can increase phosphorylation of FRQ (Pregueiro et al. 2006). It has a period-shortening 
  
24 
effect in frq+ strains. It is known that prd-3 and prd-4 have slight effects on the free-
running long period conidiation rhythm in frq10 chol-1 strains on low choline and the 
entrained conidiation rhythm in the frq10 strain. 
The prd-6 mutation has been reported to be a mutation in a gene coding for a type 1 
RNA helicase involved in translational termination and RNA metabolism (Compton and 
Feldman,  2004) and it shortens the period of the FRQ-less rhythm with geraniol 
(Lombardi et al. 2007). 
Using microarrays, three clock-controlled genes (ccgs) were identified that display 
rhythmic mRNA levels in FRQ null strains. It is suggested that these ccgs are regulated 
by FLO (Correa et al. 2003). It was also shown that ccg-16 (which is the most robustly 
rhythmic gene among ccgs) is rhythmic when FRQ levels are high; suggesting that the 
FLO oscillator that drives ccg-16 rhythms is not inhibited by high or low FRQ levels. As 
was mentioned the FRQ-based oscillator required the activity of WC-1 and WC-2 (Loros 
and Dunlap, 2001; Dunlap and Loros, 2004). However, ccg-16 rhythms do not require 
FRQ but do require WC-1 and WC-2 (de Paula et al. 2006). According to several studies 
it is proposed that in Neurospora at least three oscillators are running rhythmicity: the 
FRQ-based oscillator (Loros and Dunlap, 2001; Dunlap and Loros, 2004), FRQ/WC-
independent or FLO (Merrow et al., 1999; Lakin-Thomas and Brody, 2000; Granshaw et 
al., 2003; Christensen et al., 2004), and also WC-FLO (de Paula et al. 2006). 
Studies indicated that four prd mutations can have effects in FRQ-less rhythms in two 
conditions (prd-1 and prd-2 have the greatest effect, prd-3 and prd-4 have less effect): the 
free-running long-period conidiation in frq10 chol-1 on low choline and the heat-entrained 
conidiation rhythm in frq10 strains. Therefore, prd mutations influence FLO with and 
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without choline starvation (Li et al. 2010). Results were obtained from Lombardi et al 
that prd-1 and prd-2 altered the period in geraniol and farnesol supplementation but they 
did not abolish the FRQ-less rhythmicity (Lombardi et al. 2007). 
Another mutation that affects two FRQ-less rhythms similar to prd-1 and prd-2, is 
UV90. It can influence the free-running rhythm under low-choline conditions and the 
heat-entrained rhythm in the choline-sufficient condition. It is not known if there are 
multiple FLOs or not, and each of the products of UV90, prd-1 and prd-2 may have 
different targets that affect the function of independent FLOs. In the simplest model there 
is a single FLO, and it is assumed that UV90 and prd-1 and prd-2 gene products have one 
major target and function (Li et al. 2011).  
In the proposed model for Neurospora oscillators, FRQ/WCC and FLO 
independently affect the rhythmicity. FLO is always functioning but its output and low 
amplitude are masked by FRQ/WCC. In the absence of FRQ/WCC and addition of 
different conditions like farnesol and chol-1, FLO exhibits higher amplitude and can 
drive the conidiation rhythm or other rhythms like nitrate reductase (NR) (Christensen et 
al. 2004) and ccg-16, shown in figure 1.7 (de Paula et al. 2006). 
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Fig 1.7. The proposed model for circadian oscillators in Neurospora. This model is 
based on a single FRQ-less oscillator that is in interaction with FRQ/WCC oscillator.  
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1.11. Objective of my project 
 The prd-1 gene is known as part of FLO that affects both the period and temperature 
compensation. Previously mapping the prd-1 gene was started using rapid genetic 
mapping techniques described by Jin et al (2007). Experiments showed that the prd-1 
gene is located on the right of the AluI(a) marker on chromosome III with a 
recombination rate of 2.2%. 
My project aimed to confirm the location of the gene and also identify and 
characterize it. In order to do that, PCR and digestion by different enzymes was done to 
confirm the location of the gene. Genes in this interval were screened to check their 
phenotype. Candidate genes were sequenced to find the mutation. Several prd-1 and prd+ 
strains were sequenced to confirm that the mutation exists in all prd-1 strains and not in 
prd+ strains. cDNAs of prd-1 and prd+ were compared. The candidate gene for prd-1 was 
cloned in the his-3 targeting plasmid and then complementation was carried out. BLAST 
search showed that the prd-1 gene is an RNA helicase that has orthologs in 
Saccharomyces.   
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2. Methods and Materials 
2.1. Neurospora strains 
All Neurospora strains used in this study carry the backbone genotype bd; csp-1 as 
described previously (Lakin-Thomas, 1992). The genotype of bd; csp-1 will be referred 
to as WT (wild type) throughout this thesis. The bd mutation helps to express the conidial 
banding pattern when cultured in growth tubes or other closed culture vessels by reducing 
the sensitivity to CO2 buildup (Davis, 2000). This mutation does not have any effect on 
the circadian clock. The csp-1 (conidial separation) mutation also has no effect on clocks 
and it is used to keep the conidiospores from detaching to limit contamination (Lakin-
Thomas 2006). The chol-1 mutation is deficient in an enzyme required for 
phosphatidylcholine biosynthesis. For normal growth and development it requires choline 
supplement in the growth medium. Choline starvation reduces its growth rate and 
lengthens the period (from 21.5 hours for WT to 60 hours).  
2.2. Growth and Harvesting of Strains 
In order to obtain DNA, strains were grown in liquid minimal media which is 50X 
vogels and glucose and water (Appendix-1). One ml of media was pipetted into microtiter 
wells and a small sample of conidia of each strain was inoculated using a sterile loop. The 
samples were placed at 30oC for 2-3 days and they were harvested by vacuum filtration, 
rinsed with distilled water and covered with foil and stored at -80oC.  
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2.3. Isolation of DNA 
The method was adapted from Jin et al (2007). To isolate DNA for PCR, harvested 
fungi were placed in liquid nitrogen, and a cooled mortar and pestle were used to grind 
the frozen mycelia to fine powder. To each sample, 0.6 ml of extraction buffer 
(Appendix-1) and 3µl of proteinase K were added. After incubation in a water bath at 
65oC for 1 hour, 0.2 ml of 7.5M ammonium acetate was added and samples were 
incubated on ice for 5 minutes. Samples were centrifuged for 3 minutes at 16000 g and 
supernatants were transferred to fresh tubes.  RNAase A (5mg/ml) was added and they 
were incubated at 37oC for 1 hour, then 0.5ml of chloroform was added. After 
centrifuging the samples at 13250 g for 5 minutes the top aqueous layer was transferred 
to a fresh tube and 0.65 ml isopropanol was added. Samples were centrifuged again for 
15 min at 13250 g. Isopropanol was removed and pellets were rinsed with 1ml of 70% 
ethanol. The pellets were dissolved in 0.1ml of TE buffer (Appendix-1). DNA 
concentration was measured by nanodrop spectrophotometer. 
2.4. Primer preparation 
Primers were ordered from Invitrogen and IDT (Integrated DNA Technologies). 
Primer tubes were centrifuged several times to collect primers. The “nmole” amount on 
the information that comes with the primers was used and the appropriate amount in µl of 
sterile TE was added to the primer tube. It was mixed and centrifuged briefly to collect 
the primer. The stock solutions of primer were 1 nmol/1µl. 
For PCR a 10 µM concentration is needed, therefore each primer was diluted using 99 
µl of sterile water + 1µl of primer to get 10 µM concentration. 
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2.5. Preparation of PCR samples 
 
For CAPS markers, 50ng of DNA was used as a template. The first 4 ingredients were 
mixed in order to make a master mix. 17 µl of master mix was added to each tube and 
then 1 µl of Forward and Reverse primers and DNA template were added to each tube 
and mixed gently. The PCR program was based on New England Biolabs “Taq 
polymerase” PCR manual. 
 
•The optimal annealing temperature is 3-5oC less than average Tm of primers 
that can be found from the manufacturer’s information. 
 
To get the PCR product for cloning, LA Taq (from TaKaRa) enzyme was used. LA 
Taq combines Taq DNA Polymerase and a DNA proofreading polymerase with 3’ to 5’ 
PCR recipe Amount
Taq  10X Buffer 2  µl
Water (sterile,high quality) 14.52 µl
dNTP (10 mM) 0.4 µl
Taq  polymerase (400 units) 0.08 µl
Forward Primer (10 µM) 1 µl
Reverse Primer (10 µM) 1 µl
DNA template (50 ng/µl concentration) 1 µl
20 µl total
Step Temperature Time
Initial DNA
 denaturing
Step 1: 94oC
3 min 
(30 seconds is typical, but 2-4 min is used to
 ensure separation of GC-rich sequence)
DNA denature
 (26 cycles)
Step 2: 94oC
15 sec for a DNA fragment less that 8-900 bp,
 for a little more that 1 kb use 30 sec
Primer annealing 
(26 cycle)
ii) Varies*
15 sec 
for fragment less than 8-900 bp, for around 1 kb use 30 sec
Strand extension iii) 72oC
1min 
(typically 1 min per 1 kb, use 1 min for smaller fragments)
Final extention Step 3: 72oC 5 min (for less than 1000bp, for more use 10 min)
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exonuclease activity that is optimized for PCR amplification of very long DNA templates 
(long range PCR). The PCR recipe and program are presented below.  
 
 
2.6. Restriction Enzyme Digestion 
Using the New England Biolabs website (https://www.neb.com), it was determined if 
the enzyme needs Bovine Serum Albumin (BSA) and what temperature is needed for 
incubation and which buffer should be used. Different restriction enzymes from NEB 
were used. 
 
  
PCR recipe Amount
LA Taq  10X Buffer 10 µl
Water (sterile,high quality) 54  µl
dNTP (2.5 mM) 16  µl
LA Taq  polymerase (125 units) 2  µl
Forward Primer (10  µM) 8  µl
Reverse Primer (10  µM) 8  µl
DNA template (50 ng/ µl concentration) 2  µl
50  µl total
Steps Temperature Time
Initial denaturation 94oC 5 min
94oC 40 sec
60oC 40 sec
72oC 3 min
Elongation 72oC 10 min
Amplification
( 35 cycles)
Restriction Enzyme Recipe with BSA without BSA
Water (sterile, high quality) Varies* (14.3 µl or 13.8  µl) Varies* (14.5  µl or 14 µl)
Restriction Enzyme Buffer 2  µl 2  µl
restriction Enzyme Varies* (0.5  µl or 1  µl) Varies* (0.5  µl or 1  µl)
BSA (optional) 0.2  µl 0
DNA- PCR product 3  µl 3  µl
20  µl 20  µl
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The first 4 ingredients were mixed in this order: water, restriction enzyme buffer, 
restriction enzyme and BSA. When the master mix was ready 17 µl of master mix was 
added to 3 µl of PCR product and mixed gently. Samples were incubated in a water bath 
at the desired temperature for 1-1.5 hours. 
2.7. Gel Electrophoresis 
 
The appropriate amount of 10X TAE buffer (Appendix-1) and water were mixed to 
get 1X TAE, then agarose was added and heated in a microwave until the agarose was 
well dissolved. After cooling to about 55oC, ethidium bromide or red safe were added and 
it was poured into the gel mold. After 20-30 minutes it was ready to use. 
1X TAE was poured into the electrophoresis chamber and the gel was covered with 
buffer. Each sample was mixed with Loading Dye and loaded into wells. The gel was 
electrophoresed until blue dye had run about halfway down (small gel: 70 volts, ~ 45 
min; large gel: 100 volts, ~ 45-60 min). 
 
 
1X TAE Buffer
3 ml 10X TAE buffer
+ 27 ml water
1X TAE Buffer
15 ml 10X TAE buffer
+ 135 ml water
Agarose (1.5%) 0.45 g Agarose (1.5%) 2.25 g
Ethidium Bromide
(3%) or Red safe
EB: 0.9 µl
Red safe: 3 µl
Ethidium Bromide
(3%) or Red safe
EB: 4.5 µl
Red safe: 8 µl
Small Gel (30 ml) Large gel (150 ml)
6 X Loading
Dye 
2 µl
6 X Loading
Dye 
3 µl
6 X Loading
Dye 
1 µl
PCR product 10 µl PCR product 15 µl Ladder 1 µl
Water 4 µl
12 µl 18 µl 6 µl
Undigested
samples
Digested 
samples
Ladder
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2.8. Knockout screening in race tubes  
Knockout strains were ordered from the Fungal Genetic Stock Centre 
(http://www.fgsc.net/) and were inoculated in race tubes, which are glass 30 cm tubes that 
are open at both ends. MA media was used for race tubes (Appendix-1). The race tubes 
were placed in light and 30oC for one day and then they were transferred to constant dark 
and 22oC. The growth front was marked every day and the exact time and date of 
marking were recorded. After the growth was finished the tubes were scanned and growth 
rate and period were calculated using lab generated software called Mac Tau. 
2.9. Gene sequencing  
In order to sequence a gene, the sequence and annotation were found in the Broad 
Institute Database (http://www.broadinstitute.org). For sequencing, upstream and 
downstream sequences also were used and were found from the same database. The 
primers were designed using ApE software 
(http://biologylabs.utah.edu/jorgensen/wayned/ape/). Primers with GC content almost 
50%, Tm less that 60oC and length of 18-22 nt were chosen. Primers Forward-1 and 
Reverse-1 were used for PCR and several primers were designed (every 500nt-800nt) to 
cover the whole gene.  
PCR was carried out to amplify the gene using LA taq (as described in section 2.5). 
The PCR product was electrophoresed through a 1% agarose gel to check if the product 
size was what was expected. The PCR product was gel purified using the QIAGEN Gel 
Extraction kit according the manufacturer instructions. PCR product (5 µl) and 4µl of 
each primer were sent to the York Biology Molecular Core facility for sequencing. 
Sequencing results were aligned with the original sequence that was found from Broad 
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database using ApE software. According to Lee Wang in the core facility, the sequence 
for the first 20 and last 20 bases are not reliable. Therefore, if a missing base was seen at 
the beginning or at the end, sequencing was repeated or overlapped by the next primers to 
get more reliable results. Table 2.1 presents all the primers for PCR and sequencing the 
candidate prd-1 genes and msp-8 gene. 
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Table 2.1. List of primers used for sequencing candidate genes for prd-1 and msp-8. 
Sequence
5' ----> 3'
5703-Forward 1 GCGGATCCGGTCTCCCCCTGGTCCCG 26 bp
5703-Forward 2 CATCCAGCCATCTGGGTCATC 21 bp
5703-Forward 3 CTCATCTCAGTCACTCAGTCA 21 bp
5703-Reverse 1 TCCGGGCCCTCTCAGAAACATTGCTTA 27 bp
5703-Reverse 2 GATGACCCAGATGGCTGGATG 21bp
7845 F-1 TGTCTCCATTACTCCCTTGAAC 22 bp
7845 R-1 GGGAAGCAGATGGACTATGTATG 23 bp
7824 F-1 CGAAGTCAACTGAAGCGATAGC 22 bp
7824 F-2 GGATGGAGGGAATACAGATCAG 22 bp
7824 R-1 TACGGCCCAGTAAGATTAGACG 22 bp
7817 F-1 ACGCAACTCAACCACCATTCC 21 bp
7817 F-2 TCGGATAAGCTGGTGTGGTCG 21 bp
7817 F-3 CGTAAACGCCTTGAGTAGCTGTG 23 bp
7817 F-4 GGTGGGAAGAAACGAAACGAACG 23 bp
7817 R-1 AAGGCGCATTGCTTTACACG 20 bp
7817 R-2 TTAGCGCCTTCTCCAGGTTTC 21 bp
7839 New F-1 TGCCTTATCGGCGCTTTATC 20 bp
7839 F-1 CTCAAATCCGCCTTCGCTGTAAC 23 bp
7839 F-2 ATCCGCATCTCACATCCACTAGC 23 bp
7839 New F-2 CACCAATCCTCCATCGACATCTC 23 bp
7839 F-3 GCGGCTACTCTAACAACTACTCC 23 bp
7839 New F-3 CGAACCTGCTCATTTCCTCTCTC 23 bp
7839 F-4 CGTGAGTTGGCTGTCCAGATTC 21 bp
7839 New F-4 TTCACATCAACGCTCAGCCTC 21 bp
7839 F-5 TCAAGACTGGCAAGAGCCCTATC 23 bp
7839 New F-5 TTGTCACCGAGAGAGGGTAGTAG 23 bp
7839 F-6 GTGTCACCTGAATCTGCCCATC 22 bp
7839 F-7 ATTGCTTTCAGACGCTCACTGG 22 bp
7839 F-10 CCCAACAACTCCGAGGATTAC 21 bp
7839 R-1 ACCTTGGAACGCAGCACAAATC 22 bp
7839 R-2 CTCATCGACGTGAAACCTACAGC 23 bp
7839 R-3 GCCGAACTTGGAGATTTCTTGC 22 bp
7839 R-4 ACCTCCACCACCACTGTAGC 20 bp
7839 New R-1 TGGCGATACAGACCTCGACTC 21 bp
7839 New R-2 GCCGAACTTGGAGATTTCTTGC 22 bp
7839 New R-3 AGCCTTGACCTCGTCCATAAC 21 bp
7839 New R-4 ATGTCCCAGTTCTGCTTCTGC 21 bp
pBM61 F-1 ATTCAGACCCCATTAGCCGTCCACGCC 27 bp
pBM61 R-1 GACGGGGTAGCTTGGCCCTAATTAACC 27 bp
1143 F-1 ACCTCTAGGTACTGATGAGCCAC 23 bp
1143 F-2 CTCACGGTGCTTGTCATCAAAC 22 bp
1143 F-3 TCTGCAACGCTTGAGCAACC 20 bp
1143 F-4 GACCCGACTACAACACCATCAAG 23 bp
1143 F-5 CGGTGTTTCCTTGGCATTCAG 21 bp
1143 F-6 TATTGACCTCTGTCGCAAGCTC 22 bp
1143 F-7 GTGTCATCAAGCAGGCATTGG 21 bp
1143 F-8 AGGACTTGGAAAGAGCGCAAAC 22 bp
1143 F-9 ACATGACGGGCTTCAGCATTG 21 bp
1143 F-10 AGAGCAATGGGCATCAAGGAC 21 bp
1143 F-11 CCCGACAAGAAGTTTGCAGCATC 23 bp
1143 F-12 CTTGCATATCAACACGGCATGG 22 bp
1143 F-13 TAGTGTCTAGGAGCAGCAACAGG 23 bp
1143 R-1 GATAAACAGGCGACACCAAAGC 22 bp
1143 R-2 ACTTCGCCAAGCACGATTACG 21 bp
1143 R-3 AACTTGATGGTCTTGGCCTCC 21 bp
1143 R-4 ATGCGGCTGCCCATTCTTTG 20 bp
1143 R-5 ATCTTCATCTCCTCGCCTTCCAG 23 bp
1143 R-6 GTCTTTGGGTTCTTTGCGCTGAG 23 bp
Name Length
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2.10. RNA Extraction 
RNA of SG#26 (bd csp-1) and SG#260 (bd csp-1 prd-1) was extracted. To extract 
RNA, the strains were grown on minimal liquid media, harvested and turned into powder 
by grinding in liquid nitrogen as described earlier for DNA extraction. 1 ml of Trizol was 
added to screw-cap tubes of each sample. After vortexing, 0.2 ml choloroform was added 
to each tube and tubes were shaken for 15 seconds. They were incubated at room 
temperature for 5-12 minutes and centrifuged at 15770 g  for 15 minutes at 4oC. The top 
aqueous layer was transferred to a fresh tube, 0.5 ml of isopropanol was added to 
precipitate RNA and tubes were centrifuged at 15770 g for 8 minutes at 4 oC. The pellet 
of RNA was washed with 1 ml of 75% ethanol and centrifuged at 6160 g for 5 minutes at 
4 oC. Ethanol was removed and the dried pellet was dissolved in DEPC 
(Diethylpyrocarbonate) water. Samples were incubated in a water bath for 10-15 minutes 
at 55-60oC and stored at -80oC. The RNA concentration was measured using the 
nanodrop spectrophotometer. RNA concentrations for SG#26 and Sg#260 were 3.06 
µg/µl and 3.44 µg/µl, respectively.  
2.11. RNA to cDNA  
To make cDNA, a high capacity RNA to cDNA kit from Applied Biosystems was 
used. All procedures were conducted on ice. A master mix of 2X RT buffer (10 µl for 
each sample) and 20X RT enzyme (1 µl for each sample) was made. 9 µl of nuclease-free 
water and RNA (8 µl of nuclease-free water + 1µl of RNA sample) were mixed with 11 
µl of master mix to make 20 µl of reaction for each sample. The PCR reaction condition 
is shown below. 
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After the reverse transcription was finished, PCR with cDNA samples was done. 
Samples were mixed with loading dye and loaded on a 3% agarose gel. 
2.12. PCR product preparation for cloning 
PCR was carried out using LA taq as in section 2.5, with primers designed to have 
restriction enzyme sites that are not found inside the gene so the enzyme will not cut the 
gene. The PCR product that was carrying EcoRI restriction site was used for cloning. 
2.13. Cloning the gene into pSTblue-1 plasmid 
A mix was made of 2 µl PCR product plus 5.0 µl End Conversion Mix plus 7.5 µl 
Nuclease-free Water to a total of 10 µl. 
The reaction was incubated at 22°C for 15 min. The reaction was inactivated by 
heating at 75°C for 5 min. 
1 µl (50 ng) Blunt Vector and 1 µl (4 U) T4 DNA Ligase were added directly to the 
end-conversion reaction, to a total volume of 12 µl and they were incubated at room 
temperature for 15 min. After ligation, 1 µl of the ligation reaction and chemically 
competent cells were used for transformation and cells were plated on kanamycin plates. 
2.14. Electroporation using One Shot TOP10 Electrocompetent E.coli 
TOP10 E.coli competent cells from Invitrogen were used for transformation. These 
cells have high efficiency for cloning. Along with TOP10 Electrocomp E.coli cells, 
pUC19 plasmid (10 pg/µl) was used as a control. S.O.C (Super Optimal broth with 
Catabolite repression) medium and LB + ampicillin plates (Appendix-1) were placed at 
Step 1 Step 2 Step 3
Temperature (oC) 37 95 4
Time (min) 60 5 ∞
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37oC to be warm for transformation. A vial of One Shot TOP10 Electrocomp cells was 
used for each transformation. 1-2 µl of the DNA (10 pg-100ng) was added to a vial of 
One Shot cells and mixed gently. 1 µl of DNA (10pg for pUC19 and 5ng for pBM61) 
was used. The cells were transferred to a chilled electroporation cuvette on ice. The 
electroporator was set for bacterial transformation (600Ω, 25 uF, 2.5V) and after 
electroporation 250µl of pre-warmed S.O.C medium was added to each vial. The 
solutions were placed on a shaker for 1 hour at 37oC to allow expression of the antibiotic 
resistance gene. 10-150 µl from each transformation was spread on a pre-warmed 
selective plate and inverted plates were incubated overnight at 37oC. 
2.15. Transformation using chemically competent E.coli 
E.coli cells DH5α from glycerol stocks were streaked onto LB agar plates and 
incubated at 37oC overnight to get isolated single colonies. A 50 ml overnight culture of 
E.coli in LB broth was grown (Appendix-1) at 37oC, diluted in 500 ml LB and grown at 
37oC to OD600 of 0.3-0.4. The cells were centrifuged at 1000 g and 4
oC, pellets were kept 
ice-cold from this point and they were resuspended in one tenth volume (50 ml) ice-cold 
TSS (Appendix-1) and stored at -80oC. 
For each transformation 50 µl of chemically competent E.coli cells was used.  
Plasmid DNA (1 µl, 10 pg-100ng) was added to E.coli cells and incubated on ice for 20-
30 min. Cells were heat shocked for 45 seconds in 42oC water bath and quickly put on ice 
for 2 minutes. One ml of LB (without antibiotics) was added and shaken at 37oC and 250 
rpm (revolutions per minute) for 1 hour. The cells were plated on selective plates and 
incubated overnight at 37oC. 
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2.16. Plasmid purification 
Colonies that were grown on plates were picked with sterile toothpicks and each 
colony was grown in 3 ml LB (with antibiotics) overnight on 37oC. Using the mini prep 
QIAGEN kit, the plasmid DNA was purified according to the manufacturer’s 
instructions.  
2.17. Transformation of Neurospora 
2.17.1. Preparation of plasmid DNA 
The plasmid DNA was linearized with an enzyme that cuts once outside of the insert 
and his-3 gene. The restriction product was cleaned up using the PCR purification 
QIAGEN kit according to the manufacturer’s instructions. The concentration of DNA 
was measured by nanodrop spectrophotometer. Plasmid DNA (10-15µg ) in 15µl water 
was needed for transformation, but the DNA was not concentrated enough so it was 
precipitated to concentrate it. Plasmid DNA was diluted with water to 100µl. Sodium 
acetate (10 µl, 3M, pH 8) and 200µl absolute ethanol were added and the solution was 
kept at -80oC overnight. It was centrifuged at 18510 g, 4oC for 5 minutes and the 
supernatant was removed. The pellet was washed with 75% ethanol, centrifuged and 
dried at room temperature 10-20 minutes and dissolved in 15µl sterile water. 
2.17.2. Growth and harvest of conidia 
The his-3 strain was grown in 4-5 slants at 30oC for 4-7 days. Five 1000ml flasks 
containing 100 ml medium for growing conidia (Appendix-1) were made and the 
contents of slants were inoculated by sterile loop. Cultures were grown in constant dark at 
30oC for 3 days and then constant light at room temperature for 5-8 days.  
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Water (50 ml) was added to each flask and using a sterile loop, the conidia were 
scraped off and poured into conical tubes. This was repeated with the other flasks and 
tubes were vortexed vigorously and were poured through autoclaved muslin in a funnel 
into fresh tubes. Tubes were centrifuged at 2730 g for 5 minutes, 25oC. The supernatant 
was discarded and all pellets were pooled into one tube. The pellet was washed three 
times with 40 ml water and resuspended in residual water and kept on ice. 
2.17.3. Transformation of spores by electroporation 
Spores were centrifuged at 2730 g for 5 minutes at 4oC and the supernatant was 
removed. One ml 1M sorbitol was added and after vortex and centrifuging it was 
removed. Sorbitol (40µl 1M ) (Appendix-1) was added and spores were mixed and kept 
on ice. The results of transformation showed that 40µl 1M sorbitol was too viscous and 
transformation was not successful. Adding 2ml of sorbitol (1M) produced better results 
because the spore concentration was less.  
Plasmid DNA (15µl) was added to 250 µl of conidia, mixed gently and samples were 
put on ice for 5 minutes. Conidia and plasmid DNA were transferred to a chilled 
electroporation cuvette using a pasture pipette. The electroporator was set for fungal 
transformation (voltage: 1.5V, capacitance: 25 uF, resistance: 600 Ω). After 
electroporation 1ml recovery medium (Appendix-1) was added to the cuvette and gently 
mixed by pipetting and the mixture was transferred to a 1.5ml tube. Tubes were put on a 
shaker at room temperature for 1 hour. 
 
  
41 
2.17.4. Growth of transformants 
Two 1 ml dilutions of 1/10 and 1/100 of spores were made. Recovered spores (100 
µl) were removed and 900 µl recovery medium was added to make a 1/10 dilution. From 
the 1/10 dilution, 100 µl was removed and 900 µl recovery medium was added to that to 
make a 1/100 dilution. Each dilution was mixed well with 60 ml plating medium 
(Appendix-1) and poured into three 10 cm petri plates (20 ml per plate). Plates were 
incubated face up at 30oC for 3-7 days for colonies to grow. 
Individual colonies were punched out with the narrow tip of a pasteur pipette into 
slant tubes with minimal medium (Appendix-1) (no histidine) and incubated at 30oC to 
grow. To observe the phenotype of transformants they were inoculated in race tubes from 
slants and placed in constant light at 30oC for a day and transferred to constant dark at 
22oC. Growth rate and period were calculated using Mac Tau software. 
2.18. Microconidia preparation 
The medium for microconidia (Appendix-1) was poured into 10 cm petri plates, 20 
ml per culture. Plates were covered with sterile cellophane. The center of the cellophane 
was pierced by a sterile needle and inoculated with a few spores near the hole. Plates 
were incubated upside down at room temperature in a humid atmosphere for 7-12 days. 
The cellophane was removed and 2 ml of sterile water was poured into the plates to wash 
the surface; after a few minutes the water was removed with a sterile pasture pipette into 
sterile 1.5 ml conical tubes. Tubes were centrifuged at 21470 g for 1 minute at room 
temperature. Supernatant was removed and spores were resuspended in the residual 
water. Spores were counted using a hematocytometer and microscope. A volume that 
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contains 100 spores was calculated. Spores were plated in three different plates of 20, 100 
and 500 spores per plate. Colonies were picked after 3-5 days of growth at 30oC. 
2.19. Screening the progeny from a cross 
Crosses were set up by Dr. Lakin-Thomas and spores were picked from these crosses. 
From a plate of 4% agar, a slice was cut as big as a slide and transferred to a clean glass 
slide. A few drops of 1:10 diluted bleach was poured on the agar. Agar was cut in the 
shape of a grid that has 100 small squares. To pick spores, a flamed loop was used to pick 
up perithecia and they were placed on the agar slide under a dissecting scope. Using the 
loop, a perithecuim was broken and spores were separated and each spore placed on a 
small square of agar. Each square was placed into a baby tube containing minimal 
medium and choline (~ 170 spores were picked). Baby tubes were placed in a water bath 
at 55-60oC for 30 minutes to heat shock to induce germination. Baby tubes were kept at 
room temperature for 7-10 days to grow. 
In order to test baby tubes, the first characteristic to select is csp + or csp-1. By 
tapping the tube csp+ and csp-1 progeny were separated. Tubes with flying spores are 
csp+ and clumpy ones are csp-1. Each csp-1 progeny was inoculated in 2 race tubes 
containing MA medium (one with choline and one without choline). The chol+ and chol-
1 progeny can be separated by growth rate with and without choline. Using a hygromycin 
resistance test, it can be determined which progeny have the knockout background. Each 
progeny was inoculated in two stock tubes with 1ml minimal liquid media (one with 
hygromycin and one without hygromycin). They were placed on a shaker for 2-3 days at 
room temperature. Progeny that grew in hygromycin media (hygr) have the background 
of the knockout parent. To make a knockout strain, the knockout gene is replaced by the 
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hph cassette which confers hygromycin resistance (Colot et al., 2006). Observation on 
race tubes of growth rate and period were used to identify bd or prd mutations.  
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3.  Results 
3.1. CAPS markers and mapping 
In order to map the prd-1 mutation, mapping was performed based on single 
nucleotide polymorphisms (SNPs). In this technique co-segregation analysis of progeny 
from a single cross between a wild type and mutant strain from different backgrounds 
was done. The Oakridge and Mauriceville strains have many SNPs (Jin et al. 2007).  
The wild type strain Mauriceville (rasbd+, csp-1+, prd-1+) and Oakridge strain (rasbd, 
csp-1, prd-1) were previously crossed by Kamyar Motavaze and progeny were examined 
with Cleaved Amplified Polymorphic Sequences (CAPS) markers. The markers were 
designed to have SNPs that also act as a restriction enzyme site (Jin et al. 2007). The 
progeny with Oakridge background have the restriction site and a PCR product that 
contains the SNP will be cut while Mauriceville stays uncut. Markers in different 
locations were chosen and DNA of Mauriceville and Oakridge parents as well as prd-1 
progeny and prd+ progeny that showed recombination in this region were examined.  
 If progeny with a prd+ Mauriceville phenotype are digested it means that they have 
the SNP from the Oakridge parent and recombination had occurred during meiosis. 
Similarly, a strain with prd-1 Oakridge phenotype that remains uncut after restriction 
enzyme digestion means that it has DNA of Mauriceville background. To map the gene, 
the recombination frequency was calculated to find the approximate distance between 
markers. The higher the recombination rate, the further the marker is from the mutant 
gene.   
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From previous experiments done by Kamyar Motavaze it was found that the prd-1 
gene should be located between AluI (a) marker and the centromere (Fig.3.1). The 
purpose of this experiment was to confirm the location of prd-1. Therefore, based on 
previous experiments, primers were chosen to do PCRs and digestion with different 
restriction enzymes (Table.3.1). Progeny were chosen that should have a recombination 
event in this region, based on previous results with CAPS markers mapping. A summary 
of digestions is shown in Table 3.2. My result confirmed the location of the gene.  The 
results with the TSP 509 I enzyme were not consistent with Kamyar’s result. The TaqI(a) 
and TaqI(b) results were also not consistent with Kamyar’s results probably due to using 
old enzymes. The TaqI(a) and TaqI(b) markers also did not give consistent results with 
the control strains: all Oakridge controls should be cut but some were uncut. Therefore 
the results with TSP 509I and TaqI(a) and TaqI(b) were disregarded. The rest of the 
digestions showed that prd-1 should be somewhere between HaeIII and MspI markers. 
The PCR results and digestions with different restriction enzymes are shown in figures 
3.3 - 3.11. 
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Table 3.1. Markers with SNP details and primer sequence. Numbers under SNP 
Detail identify the position of the SNP on linkage group 3. 
 
 
Fig 3.1. Marker locations on linkage group III of Neurospora crassa. It was predicted 
that the prd-1 gene is between HaeIII marker and MspI marker.  
 
MseI
3_641804_A → G_MseI +  640804-642804 + F-  GCTAGTCTCCTTGAGATCGTCCC
R-  GTGACGATCAGCGCAAACT
641804-F 
641804-R
359 bp TTAA
TaqI (b)
3_1212329_C →T_TaqI  +  1211329 - 12133329 + F-  CATTGCAAGTCCTCTCCAAA
R-  GTTCTGTGCGTGGAGTACAAC
1211329-F 
1211329-R
358 bp TCGA
AluI (b)
3_1502999_C →T_AluI  +  1501999 - 1503999+ F-  CATATGTATCCGTCTACGCCAC
R-  GGCTGGGTCTCGTTTTCTCT
1501999-F  
1501999-R
358 bp AGCT
HeaIII
3_1083480_C →T_HaeIII +  1082480 - 1084480+ F-  GACACTGGATTGTAACTTCGACG
R-  CATCCGAGATTTTCTCACAAGAA
108348-F  
108348-R
354 bp GCCC/CCGG
MspI
3_545271_G →A_MspI +  545000-546000 + F-  AACACGCTATTCGCTCATTTG
R-  CGTTTTCGCTGTCTTGTTCTGTG
545000-F  
545000-R
957 bp CCGG
TaqI (a)
3_578038_C →T_TaqI +   577600-579000 + F-  CAGTACTTGTAGATAGTCTTGCATCG
R-  GCACTCCTCGGTGTAGTACACACTT
577600-F 
579000-R
1350 bp TCGA
BstUI
3_597381_C →G_BstUI +   597000-598400 + F-  TGTAAGGAAAGCTGAGATATCCTAG
R-  CGATTTTCAGAGAGAGCTTGTACGG
597000-F 
598400-R
1351 bp CGCG
Tsp509I
3_515957_C →T_Tsp509I +  515731-516168 + F-  GTGAGCCAGATGACGTTGTG
R-  GTTCAGCCCAGCTTCCCTAT
P-21 
Q-21
398 bp AATT
AluI (a)
3_639318_C →T_AluI +  639225-639524 + F-  TGGGCGGTCAACTCCAAAGG
R-  CAGGGCAACTTGTTTGGGCT
3-17-AluI-F  
3-17-AluI-R
260 bp AGCT
Enzyme siteMarker SNP Detail Position
Primer sequence
5' --->3'
PCR sizePrimer's Name
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Table 3.2. PCR and digestion results of different CAPS markers. Yellow is 
Mauriceville sequence and purple is Oakridge sequence. TaqI(a) and TaqI(b) column 
were not included in the table because the control results were not consistent. Orange is 
the inconsistent result with previous result.  
17 prd-1  Cut Uncut Cut Cut Cut Cut Cut
44 prd-1 Cut Uncut Cut Cut Cut Cut Cut
46 prd-1 Cut Uncut Cut Cut Cut Cut Cut
A7 prd-1 Uncut Uncut Cut Cut Cut Cut Cut
A57 prd+ Uncut Uncut Uncut Uncut Uncut Cut Cut
SG#258 Mauriceville Uncut Uncut Uncut Uncut Uncut Uncut Uncut
SG#259 Oakridge (OR)  Cut Cut Cut Cut Cut Cut
SG#1
prd+ (Oakridge 
background)
Cut Cut Cut Cut Cut Cut Cut
SG#250(a)
prd -1(Oakridge 
background)
 Cut Cut Cut Cut Cut Cut Cut
SG#250(b)
prd-1 (Oakridge 
background)
Cut Cut Cut Cut Cut Cut
SG#80
prd+ (Oakridge 
background)
Cut Cut Cut
SG#213
prd+ (Oakridge 
background)
Cut Cut Cut
Progeny 
from the 
cross
Controls
                                                            Restriction Enzyme
Progeny # Phenotype Tsp509I HaeIII MspI BstUI AluI (a) MseI AluI(b)
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Fig 3.2. 1 kb DNA ladder from New England BioLabs was used in all 
experiments. 
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Fig 3.3. PCR for marker MseI. Top lanes are PCR product before digestion, bottom 
lanes are after 1 hour digestion by MseI enzyme. A57 and SG#258 stay uncut and this 
result is consistent with previous results obtained by Kamyar Motavaze. 
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Fig 3.4. PCR with primers 3-17 AluI-F and 3-17 AluI-R for marker AluI(a). Top 
lanes are PCR product before digestion and bottom lanes are after 1 hour digestion by 
AluI. A57 and SG#258 are uncut. 
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Fig 3.5. PCR with primers 1501999-F and 1501999-R for marker AluI(b). Top lanes 
are PCR product and bottom lanes are after digestion by AluI. SG#258 stays uncut. 
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Fig 3.6. PCR with primers 545000-F and 546000-R for marker MspI. PCR products 
are shown in black and after digestion by MspI they are shown in red. SG#1 and SG#250 
are cut. 
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Fig 3.7. PCR with primers108348-R and 108348-F for marker HaeIII. Top lanes are 
PCR product and bottom lanes are after digestion by HaeIII. SG#258 stays uncut. 
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Fig 3.8. PCR with primers P21 and Q21 for marker TSP509I. Top lanes are PCR 
product and bottom lanes are after digestion by TSP509I. prd-1 progeny 17, 44, 46 are 
cut which shows inconsistent result. Non-specific bands can be seen in this gel picture. 
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Fig 3.9. PCR with primers 597000F and 598400R for marker BstUI. Top lanes are 
PCR product and bottom lanes are after digestion by BstUI. A57 and SG#258 are uncut. 
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Fig. 3.10. PCR with primers 1211329F and 1211329R for marker TaqI(b). Top lanes 
are PCR product and bottom lanes are after digestion by TaqI. SG#250, SG#259 and 
SG#258 are uncut. 
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Fig. 3.11. PCR with primers 577600-F and 577600-R for TaqI(a). Top lanes are PCR 
product and bottom lanes are after digestion by TaqI. SG#1, SG#258, SG#80 and 
SG#213 are cut. 
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3.2. Screening knockouts and sequencing 
After determining the approximate region of the prd-1 gene, screening knockout 
mutants in this interval was the next step toward identifying the gene. To make knockout 
genes, genes were replaced by the hph cassette which confers hygromycin resistance 
(Colot et al. 2006). Using the Broad Institute database website (www.broadinstitute.org) 
and genome annotations in the database, the genes in that specific interval (between 
HaeIII and MspI markers) were found. A number of knockouts in this region (left of 
centromere) from the Fungal Genetics Stock Center were already ordered by Keyur 
Adhvaryu and they were available in the lab and they were screened in race tubes. Period 
and growth rate for all the tubes were calculated using Mac Tau software.  
Table 3.3 and 3.4 present lists of knockout genes screened in two experiments. 
Among 33 knockouts (Table 3.3 and 3.4) only one gene (NCU05703) had a slow growth 
rate (~ 1.6 mm/hr), which is a characteristic of the prd-1 mutation in addition to a long 
period. The knockouts are not carrying the bd mutation therefore they do not show any 
bands and period. The phenotype of NCU05703 is shown in figure 3.12 in comparison to 
controls.  
On the right side of the centromere there are 32 genes which are listed in Table 3.5 
(data collected from Broad Institute Database). From this list some of them were chosen 
based on their function and the knockout genes were ordered from FGSC and screened 
for growth rate on race tubes. Table 3.6 presents the phenotype of the knockout genes 
from FGSC. Among these knockouts FGSC#11688 (NCU07817) exhibits a slow growth 
rate and therefore it could be one of the candidates for the prd-1 gene.  
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In order to sequence the candidate genes, primers were designed for PCR and 
sequencing (each interval covers 500bp-800bp). Around 200-400bp was included for 
upstream and downstream regions. PCR was carried out using genomic DNA from strain 
SG#250 (bd csp prd-1) to amplify the gene and the PCR product was electrophoresised 
through a gel and gel purified (Fig.3.13). The DNA samples and primers were sent to 
York Biology Molecular Core facility for sequencing. After alignment of the sequencing 
results, no mutations were found in these two genes, therefore they are not the prd-1 
gene.  
Some of the genes from table 3.5 were chosen according to their function, for which 
knockouts were not available in FGSC and these genes were sequenced directly without 
screening. Primers were designed and PCR with SG#250 DNA was carried out and the 
samples were sent to York Biology Molecular Core facility for sequencing. Table 3.7 lists 
the sequenced genes with the number of upstream and downstream base pairs, location of 
the genes and forward and reverse primers. NCU07839 is the only gene that showed a 
mutation. To check whether this mutation exists in all prd-1 strains, DNA was extracted 
from three prd-1 progeny (17, 44, and 46) and the sequencing was repeated for them. 
DNA samples from SG#1 and SG#170 were also sequenced. In all prd-1 strains this 
particular mutation could be seen, however in the wild type and prd+ progeny this 
mutation was absent (table 3.8). Figure 3.14 shows the alignment of wild type 
NCU07839 sequence and mutant. 
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Table 3.3.  List of knockout genes screened in the first experiment, grown on race 
tubes. Growth rate and period were calculated by Mac Tau software. The bd mutation 
slows the growth rate and the knockouts grow fast because they are bd+. 
 
15744 a NCU05730.2 2.49 0
17654 A NCU05699.2 2.72 0
17655 A NCU05701.2 2.84 0
17657 a NCU05702.2 2.66 0
17658 a NCU05704.2 2.68 0
17659 A NCU05711.2 2.78 0
17660 a NCU05718.2 2.67 0
17717 A NCU05698.2 2.70 0
18004 A NCU05703.2 1.60 0
18005 A NCU05707.2 2.71 0
18007 A NCU05724.2 2.70 0
18008 A NCU05727.2 2.73 0
18009 A NCU05729.2 2.63 0
18075 A NCU05705.2 2.82 0
18076 A NCU05712.2 2.64 0
18077 a NCU05713.2 2.67 0
18079 A NCU05722.2 2.59 0
18080 A NCU05728.2 2.49 0
18786 A NCU05697.2 2.43 0
20883 A NCU05723.2 2.24 0
21583 a NCU10596.2 2.66 0
SG#259 a O.R 2.46 0
SG#170 a bd prd-1 0.95 29.475
SG#4 A bd 1.12 26.71
FGSC # Mating Type Genotype Growth Rate Period
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Table 3.4. List of knockout genes in the second experiment, grown on race tubes. 
Growth rate and period were calculated by Mac Tau software. 
 
12095 A NCU05685.2 2.69 0
12463 a NCU05710.2 2.89 0
13496 a NCU05693.2 2.24 0
13679 A NCU05716.2 2.74 0
13682 A NCU05735.2 2.82 0
13808 a NCU05715.2 2.65 0
13982 A NCU05706.2 2.93 0
17714 a NCU05691.2 2.9 0
18010 A NCU05732.2 2.89 0
18875 A NCU05731.2 2.89 0
18924 A NCU05733.2 2.97 0
19933 a NCU05694.2 2.88 0
19937 A NCU05721.2 2.81 0
SG#4 A bd 1.11 28.39
SG#170 a bd prd-1 0.87 30.79
SG#259 a WT 2.89 0
SG#1 bd csp-1 1.21 21.55
SG#250 bd csp-1 prd-1 0.74 23.68
17 bd csp-1 prd-1 0.95 23.43
41 bd csp-1 prd-1 0.54 24.87
A7 bd csp-1 prd-1 0.55 27.73
A57 bd csp-1 2.57 19.97
FGSC # Mating Type Genotype Growth Rate Period
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Fig 3.12. Screening of NCU05703 (FGSC#18004) on race tubes compared to 
controls. They were grown from left to right. Pen marks indicate 24 hour growth 
intervals.  
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Table 3.5. List of the genes on the right side of centromere between centromere and 
HaeIII marker collected from Broad Institute database. 
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Table 3.6. List of knockout genes ordered from Fungal Genetic Stock Centre 
(FGSC). Growth rate and period were calculated by McTau software. 
18136 A NCU07844.2 1.71 0
19588 A NCU07819.2 1.66 0
19591 A NCU07820.2 1.62 0
19593 A NCU07822.2 1.45 0
20493 A NCU07833.2 1.55 0
13786 a NCU07836.2 1.45 0
14353 a NCU07823.2 1.55 0
14940 A NCU07818.2 1.64 0
18132 a NCU07827.2 1.76 0
18133 A NCU07841.2 1.61 0
11688 A NCU07817.2 0.89 0
11969 A NCU07816.2 1.64 0
12027 a NCU07840.2 1.59 0
12075 a NCU07834.2 1.47 0
13121 a NCU07837.2 1.72 0
21085 a NCU07821.2 1.53 0
SG#170 a bd prd-1 0.83 26.5
SG#259 a WT 1.56 0
SG#4 A bd 1.05 26.062
FGSC# Mating Type Genotype Growth Rate Period
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Fig 3.13. PCR of NCU07817 with SG#250 DNA as template (left). Second gel (right) 
is after gel purification with QIAGEN kit to show the concentration for sequencing. 
Similar gels were run for other sequenced genes. 
 
 
Table 3.7. List of sequenced genes, their location and forward, reverse primers. 
 
568977-570929 F-1  5'  GGTCTCCCCCTGGTCCCG  3'
562nt up, 499nt down R-1  5' TCTCAGAAACATTGCTTA  3'
973002-974293 F-1  5'  ACGCAACTCAACCACCATTCC   3'
182nt up, 44nt down R-1  5'  AAGGCGCATTGCTTTACACG  3'
986420-989493 F-1  5'  CGAAGTCAACTGAAGCGATAGC  3'
483nt up, 456nt down R-1  5'  TACGGCCCAGTAAGATTAGACG  3'
1073379-1074790 F-1  5'  TGTCTCCATTACTCCCTTGAAC  3'
313nt up, 321nt down R-1  5' GGGAAGCAGATGGACTATGTATG  3'
1037113-1041895 F-1  5'  CTCAAATCCGCCTTCGCTGTAAC  3'
356nt up, 374nt down R-1  5'  ACCTTGGAACGCAGCACAAATC  3'
Locus Gene Location PCR Forward and reverse primers Mutation
YESNCU07839
569539-570430 
973184-974249 
986903-989037
1073692-1074469
1037469-1041521
NCU05703
NCU07817
NCU07824
NCU07845
NO
NO
NO
NO
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Table 3.8. List of sequenced prd-1 and prd+ progeny to confirm the mutation can be 
seen in all prd-1 progeny 
 
SG#1 w.t NO
SG#170 bd prd-1 YES
SG#250 bd csp-1 prd-1 YES
17
44
46
A57
56
62
prd-1
prd+
YES
NO
Strain Genotype Observed mutation
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Fig 3.14. Alignment of w.t NCU07839 sequence (top) and mutant DNA sequence 
(bottom) (mutation of G  A is show by #). Only alignment with primer F-5 is shown. 
Every 10 nucleotides are scaled by *.  
  
  
69 
 
3.3. Characterizing the mutation 
Annotation of the gene using the Broad Institute Database shows the gene has four 
introns that are 138 bp, 520 bp, 63 bp and 57 bp respectively that should be removed by 
RNA splicing to generate the final mature RNA product of the gene. After aligning the 
sequences, it was found that the mutation is located on the first base of the third intron 
(G→A) and may prevent the third intron from being spliced (Fig.3.15) 
In order to check the effect of this mutation on splicing, RNA was extracted and using 
an RNA to cDNA kit, cDNA of wild type and mutant was made. As shown in figure 3.15 
primers were designed to cover the specific intron. After PCR and electrophoresing  the 
product on a gel it can be seen that the size of the band in WT and mutant does not show 
a difference in the size of the intron (which is 63 bp), therefore the mutation does not 
disrupt splicing completely (Fig.3.16). Since there is a difference in brightness of bands 
between WT and mutant cDNA, the bands were cut and sent for sequencing. Alignment 
of WT and mutant cDNA showed that this mutation has an effect on splicing and splicing 
does not occur properly: there is an extra G and A in the mutant cDNA (Fig.3.17). This 
will change the reading frame and influence the amino acid sequence. This gene is an 
RNA helicase and the amino acid sequence of wild type shows that it contains a DEXDc 
domain and a HELCc domain. Based on cDNA alignment it was found that this mutation 
affects the amino acid sequence as shown in figure 3.18 and 3.19. 
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  CTTCCTTCCTTCCACCCACCCTCCATCTCCAATATCCCTTCCCGCCTACTTCTTGCGATTCTGCAAGATT  < 70 
           10        20        30        40        50        60  
 
 
   
  CTTCATCCGCGATCCTTCTTTAACCAGTCGGACTGCTTACTTGTAACCACTTCACGCGTGTCGTTTGGTT  < 140 
           80        90        100       110       120       130  
 
 
   
  CTTGTCTCTAGACGTCTGTCTTTTCCGACGTCTTCTTTTCCCGACAATCGATACCCTTGCGCCTCTAGGC  < 210 
           150       160       170       180       190       200  
 
 
   
  CTTGTTTGCTCGTCGTTTCGGTCTACCCTTCAGCAACCCCAATAACAACCGATCTTCAATTTTCAACCTT  < 280 
           220       230       240       250       260       270  
 
 
   
  TTCTTAAACAACCAGCAAACATGTCCGGATCTTACGGCGGCGGCGGCTACGGTGGCCGCGGTGGCGGTGG  < 350 
           290       300       310       320       330       340  
 
 
   
  TGGTGGATATTCTAACGGGTACGATCGCAATGGCGGCGGCTACTCTAACAACTACTCCTCACACGGGTAT  < 420 
           360       370       380       390       400       410  
 
 
   
  GATGTTTTAGCGCGAACCTGCTCATTTCCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCT  < 490 
           430       440       450       460       470       480  
 
 
   
  CTCTCTCTCTCTCTCTCTCTCTCTTTGCATTTCAAGATCAAATTGCTAACATCTGGTTCAACAGTGGCTC  < 560 
           500       510       520       530       540       550  
 
 
   
  GAATGGCTACGGAGGCGGCGGCGGAGGATATGGCGGCGGTGGTGGTGGCTACGGAGGCGGCGGCTACGGT  < 630 
           570       580       590       600       610       620  
 
 
   
  GGTGGTGGCGGCGGTGATAGGATGTCTGCTCTCGGTGCTGGTCTGCAGAAGCAGAACTGGGACATGAGCG  < 700 
           640       650       660       670       680       690  
 
 
   
  CTCTTCCCAAGTTCGAGAAGTCCTTCTACCAAGAGCATCCTAGCGTCGCCAACCGATCTCCTGCTGAGGT  < 770 
           710       720       730       740       750       760  
 
 
   
  CGACAAGTTCCGCGCAGACCACTCCATTGCCGTCTTCGGTAACAACGTTCCCAAGCCTGTCGAGACCTTC  < 840 
           780       790       800       810       820       830  
 
 
   
  GACGAGGCTGGTTTCCCTCGCTACGTTATGGACGAGGTCAAGGCTCAGGGTTTCCCTGCTCCTACTGCCA  < 910 
           850       860       870       880       890       900  
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  TTCAGTCGCAGGGCTGGCCCATGGCCCTTTCTGGTCGCGATGTCGTCGGTATTGCCGAGACCGGTTCCGG  < 980 
           920       930       940       950       960       970  
 
 
   
  AAAGACGCTCACCTACTGCCTTCCCGCCATCGTTCACATCAACGCTCAGCCTCTCCTCGCTCCCGGCGAT  < 1050 
           990       1000      1010      1020      1030      1040  
 
 
   
  GGCCCTATCGTCCTCATCCTCGCCCCTACCCGTGAGTTGGCTGTCCAGATTCAGCAAGAAATCTCCAAGT  < 1120 
           1060      1070      1080      1090      1100      1110  
 
 
   
  TCGGCAAGTCGTCCCGCATTCGCAACACCTGCGTCTACGGTGGTGTCCCCAAGGGTCCCCAGATTCGCGA  < 1190 
           1130      1140      1150      1160      1170      1180  
 
 
   
  TCTTTCCAGGGGAGTCGAGGTCTGTATCGCCACCCCCGGCCGTTTGATCGATATGCTCGAGTCTGGCAAG  < 1260 
           1200      1210      1220      1230      1240      1250  
 
 
   
  ACCAACCTCCGTCGTGTCACCTACCTTGTCCTCGATGAGGCTGATCGCATGTTGGACATGGGTTTCGAGC  < 1330 
           1270      1280      1290      1300      1310      1320  
 
 
   
  CCCAAATTCGCAAGATCATCGGCCAGATTCGCCCTGATCGTCAGACTCTCATGTGGTCTGCTACCTGGCC  < 1400 
           1340      1350      1360      1370      1380      1390  
 
 
   
  CAAGGAGGTCCGCAACTTGGCCGCCGACTTCTTGACCGACTTCATCCAGGTCAACATCGGTTCCATGGAT  < 1470 
           1410      1420      1430      1440      1450      1460  
 
 
   
  TTGGCTGCCAACCACCGTATCACCCAGATCGTCGAGGTTGTTTCCGAGTCCGAGAAGCGTGATCGCATGA  < 1540 
           1480      1490      1500      1510      1520      1530  
 
 
   
  TCAAGCATCTTGAGAAGATTATGGAGGGCCGCGAGAACCAGAACAAGATCCTCATCTTCACCGGCACCAA  < 1610 
           1550      1560      1570      1580      1590      1600  
 
 
   
  GCGTGTCGCCGACGACATCACCCGCTTCCTCCGCCAGGACGGCTGGCCCGCTCTTTCCATCCACGGCGAC  < 1680 
           1620      1630      1640      1650      1660      1670  
 
 
   
  AAGCAACAGAACGAGCGTGACTGGGTTTTGGACCAGTTCAAGACTGGCAAGAGCCCTATCATGGTTGCCA  < 1750 
           1690      1700      1710      1720      1730      1740  
 
 
   
  CCGACGTGGCTTCTCGTGGTATCGGTATGTATCCATCTTACCCCTCCGCCCTGCCCAAACCCCTCCCCCC  < 1820 
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           1760      1770      1780      1790      1800      1810  
 
 
   
  TTCTTCTCTCCCCCATCTCAGGCGACTTCCAGCATACGTACGTGCTTGTGCTTTACTCTTATGTCTAGGG  < 1890 
           1830      1840      1850      1860      1870      1880  
 
 
   
  GCTCTCTTGATTGCGCGAACTTGCCTGACCTCGTGTCGACTTGGTCTATCTGAGTGGAGTCTTGGGTTCG  < 1960 
           1900      1910      1920      1930      1940      1950  
 
 
   
  TGACGTAGCAGAAACAGTGGACTATGCTACGCCCGCGTGATTCTTCAATTGTACCTTTTTATCCCAGTTG  < 2030 
           1970      1980      1990      2000      2010      2020  
 
 
   
  TGGTACAAGCGAGGAGTAGGCATTTCTTGATTCCCGTCAAGCTTGTCTCCAAGATTCCCAAGGGGATTTG  < 2100 
           2040      2050      2060      2070      2080      2090  
 
 
   
  CATGCATGGCCCAAGGATCTCTGGAACCTTGGATCCCAACCCGGCATATTTTTCGCAATGGACAGCCCAC  < 2170 
           2110      2120      2130      2140      2150      2160  
 
 
   
  CTGCCAAGGAGAGAAGTACTACCAGAGGATCACAGAACATACCTAGATATTCGTGTTCTCCGTCCGTTCT  < 2240 
           2180      2190      2200      2210      2220      2230  
 
 
   
  GGAATGTCGTTATTCCAAACCCTGCTATTGCTAACCACGGTCCTTTAAAAAAAGATGTGCGCAACATTAC  < 2310 
           2250      2260      2270      2280      2290      2300  
 
 
   
  TCACGTGCTCAACTATGACTACCCCAACAACTCCGAGGATTACATCCATCGTATCGGCCGAACTGGTCGT  < 2380 
           2320      2330      2340      2350      2360      2370  
 
 
   
  GCCGGTGCGAAGGGTACTGCCATTACTTTCTTCACCACTGACAGTAAGTGTCACCTGAATCTGCCCATCC  < 2450 
           2390      2400      2410      2420      2430      2440  
 
 
   
  TTAGCCGAACGAAATTCTAATGTTATCTCTCCACAGACTCCAAGCAGGCTCGTGAGCTCGTCGGTGTGCT  < 2520 
           2460      2470      2480      2490      2500      2510  
 
 
   
  TCAAGAAGCTAAGCAGCAGATTGACCCTAGACTTGCCGAGATGGCTCGCTACAGTGGTGGTGGAGGTGGC  < 2590 
           2530      2540      2550      2560      2570      2580  
 
 
   
  CGCTTCGGTGGCTATCGCGGCCGTGGCGGCGGTGGATGGCGCGGTGGTAAGTCATTTTCACGCAGGTGAA  < 2660 
           2600      2610      2620      2630      2640      2650  
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  TTTGGCAGTTCCAATCCTAATAACCCTCATTAGGCCGTGGCGGCGGTGGTGGCGGCGGCTCCGTCGGTGG  < 2730 
           2670      2680      2690      2700      2710      2720  
 
 
   
  TGCTAATGCTCTTCCGCTTAACAACCGCCGGTGGTAAAGCACCACTTGAAGCGAATCAGCACATATCAAT  < 2800 
           2740      2750      2760      2770      2780      2790  
 
 
   
  TGACCTTCCTGGTCCAATCCATTGTCGCCATGGTCATTCCACACGACGAATGGCCCATTACAGCGACAAT  < 2870 
           2810      2820      2830      2840      2850      2860  
 
 
   
  TTCGACCTCGAACATGATCACGGCGTTTTAGTAGAGGATACGGTCTAGAGGTTGGTTTATTGCTTTCAGA  < 2940 
           2880      2890      2900      2910      2920      2930  
 
 
   
  CGCTCACTGGTGTCTGTTTTCACCTTGACGTCTAGGTGGTATGGGTGTGGCTTTGTTCTTTTTTTCTCGT  < 3010 
           2950      2960      2970      2980      2990      3000  
 
 
   
  ATTCCCTTATTGTCATGCTTGCGGGTTACTATTTTCACTGAGGTCAGCCGGGGTTCCAAAATTTTCCTTC  < 3080 
           3020      3030      3040      3050      3060      3070  
 
 
   
  ATTTTTTCGGAAAGTCTCATCTACAGGTCATGTTGCACCACAACTGCACTTGCAGATCATCAAACTGTCC  < 3150 
           3090      3100      3110      3120      3130      3140  
 
 
   
  AGGTCAAGATGGCCGGGTTTTATACCCTTCACCATATCTCGTCATGCCATTGCTCCGTCAAGGCATTATA  < 3220 
           3160      3170      3180      3190      3200      3210  
 
 
   
  TGACTTATGACGACGGCTTATCAGTCGAGGTGTGAACAAGAGATTTCAACTCTCTTGCTTCCCTAACAGG  < 3290 
           3230      3240      3250      3260      3270      3280  
 
 
   
  ACGGGCGCAGGCTTCTCGCCTCTCATCCTCGTTGATTAGTGATGATCTTACCGCAGACTTGTGGTAGCAG  < 3360 
           3300      3310      3320      3330      3340      3350  
 
 
   
  TCGATAGGTACTATCCTCTGCTTTTTGTGTTGTACAATAGGAAGAGGATCCTTTTCAAAGCATCACGGCT  < 3430 
           3370      3380      3390      3400      3410      3420  
 
 
   
  TGAAAGATTTTCGAAGGATCTGTCTAGTCACCAAGAGAGTCAGAGATAAACACGCGCTTTGTTTGCGCCC  < 3500 
           3440      3450      3460      3470      3480      3490  
 
 
   
  TTGGGCGCTGCAAGACTACTGCTCACCAGCTGGGTGGGATGTTTACGGTAATTGTCACCGAGAGAGGGTA  < 3570 
           3510      3520      3530      3540      3550      3560  
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  GTAGAAATGAACTGGGTAGGTCTCCAAAGAAAGATACAGATACCCTTTATGCTTAGATGGAAAAGAACAT  < 3640 
           3580      3590      3600      3610      3620      3630  
 
 
   
  TTACGCTAG  < 3649 
 
 
 
Fig 3.15. NCU07839 gene. Start and stop codons are shown in turquoise color.  
Introns are shown in red, the mutation at the beginning of the intron shown in green. 
Primer F-10 and R-4 (shown in purple) were used for amplifying the region of DNA 
which contains this intron. 
 
 
Fig 3.16. PCR of cDNA from wild type and prd-1 on 3% agarose gel 
 
 
Fig 3.17. Alignment of part of wild type and prd-1 cDNA after sequencing. 
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Fig 3.18. Wild type amino acid sequence and protein domains. Purple and green are 
low complexity regions, red is DEXDc domain and blue is HELICc domain. 
 
                                      *                                  *                                  *                                   *                                  *
1 MSGSYGGGGYGGRGGGGGGYSNGYDRNGGGYSNNYSSHGGSNGYGGGGGGYGGGG 55
                                      *                                  *                                  *                                   *                                  *
56 GGYGGGGYGGGGGGDRMSALGAGLQKQNWDMSALPKFEKSFYQEHPSVANRSPAE 110
                                      *                                  *                                  *                                   *                                  *
111 VDKFRADHSIAVFGNNVPKPVETFDEAGFPRYVMDEVKAQGFPAPTAIQSQGWPM 165
                                      *                                  *                                  *                                   *                                  *
166 ALSGRDVVGIAETGSGKTLTYCLPAIVHINAQPLLAPGDGPIVLILAPTRELAVQ 220
                                      *                                  *                                  *                                   *                                  *
221 IQQEISKFGKSSRIRNTCVYGGVPKGPQIRDLSRGVEVCIATPGRLIDMLESGKT 275
                                      *                                  *                                  *                                   *                                  *
276 NLRRVTYLVLDEADRMLDMGFEPQIRKIIGQIRPDRQTLMWSATWPKEVRNLAAD 330
                                      *                                  *                                  *                                   *                                  *
331 FLTDFIQVNIGSMDLAANHRITQIVEVVSESEKRDRMIKHLEKIMEGRENQNKIL 385
                                      *                                  *                                  *                                   *                                  *
386 IFTGTKRVADDITRFLRQDGWPALSIHGDKQQNERDWVLDQFKTGKSPIMVATDV 440
                                      *                                  *                                  *                                   *                                  *
441 ASRGIDVRNITHVLNYDYPNNSEDYIHRIGRTGRAGAKGTAITFFTTDNSKQARE 495
                                      *                                  *                                  *                                   *                                  *
496 LVGVLQEAKQQIDPRLAEMARYSGGGGGRFGGYRGRGGGGWRGGRGGGGGGGSVG 550
                                      *                                  *                                  *                                   *                                  *
551  GANALPLNNRRW* 562
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Fig 3.19. prd-1 amino acid sequence and protein domains. Purple and green are 
low complexity regions; red is DEXDc domain and blue is HELICc domain. From 
amino acid 489 the sequence is different in wild type and mutant. 
  
                                      *                                  *                                  *                                   *                                  *
1 MSGSYGGGGYGGRGGGGGGYSNGYDRNGGGYSNNYSSHGGSNGYGGGGGGYGGGG 55
                                      *                                  *                                  *                                   *                                  *
56 GGYGGGGYGGGGGGDRMSALGAGLQKQNWDMSALPKFEKSFYQEHPSVANRSPAE 110
                                      *                                  *                                  *                                   *                                  *
111 VDKFRADHSIAVFGNNVPKPVETFDEAGFPRYVMDEVKAQGFPAPTAIQSQGWPM 165
                                      *                                  *                                  *                                   *                                  *
166 ALSGRDVVGIAETGSGKTLTYCLPAIVHINAQPLLAPGDGPIVLILAPTRELAVQ 220
                                      *                                  *                                  *                                   *                                  *
221 IQQEISKFGKSSRIRNTCVYGGVPKGPQIRDLSRGVEVCIATPGRLIDMLESGKT 275
                                      *                                  *                                  *                                   *                                  *
276 NLRRVTYLVLDEADRMLDMGFEPQIRKIIGQIRPDRQTLMWSATWPKEVRNLAAD 330
                                      *                                  *                                  *                                   *                                  *
331 FLTDFIQVNIGSMDLAANHRITQIVEVVSESEKRDRMIKHLEKIMEGRENQNKIL 385
                                      *                                  *                                  *                                   *                                  *
386 IFTGTKRVADDITRFLRQDGWPALSIHGDKQQNERDWVLDQFKTGKSPIMVATDV 440
                                      *                                  *                                  *                                   *                                  *
441 ASRGIDVRNITHVLNYDYPNNSEDYIHRIGRTGRAGAKGTAITFFTTDKTPSRLV 495
                                      *                                  *                                  *                                   *                                  *
496 SSSVCFKKLSSRLTLDLPRWLATVVVEVAASVAIAAVAAVDGAVAVAAVVAAAPS 550
                                      *                                  *                                  *                                   *                                  *
551  VVLMLFRLTTAGG 563
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3.4. Cloning the candidate gene 
To confirm the identity of the candidate gene it is necessary to do a complementation 
test. The first step for complementation is to clone the gene into the his-3 targeting 
plasmid (pBM61) (Fig.3.20). The next step is to transform the plasmid into a prd-1, his-3 
strain and assay the rescued phenotype. This integration into the chromosome of pBM61 
plasmid with its insert occurs by double crossover (Fig.3.21). Integration of an insert at 
the his-3 locus happens without duplication of the his-3 sequence and reconstitutes the 
his-3+ phenotype. Selection is applied for His+ colonies after transformation. 
Cloning was done first into the pSTblue-1 plasmid (Fig.3.26) and then after cloning 
to that plasmid the insert was subcloned into pBM61. Cloning into the pSTblue-1 plasmid 
was done using the EcoRI construct. This cloning was tried twice. In the first trial 
colonies were found on the plates and they were picked and tested using HindIII (2 bands 
of 6 kb and 2.5 kb were expected) and BamHI (4 bands were expected), but the DNA did 
not show the expected size after digestions (Fig. 3.27 and 3.28). In the second trial with 
pSTblue-1 plasmid the DNA was tested with BamHI and colonies 10 and 16 showed the 
expected size after digestion (Fig.3.29). These two were tested with HindIII and DNA 
from colony 10 showed the expected size and therefore the insert seemed to be in the 
right place (Fig.3.30). 
This cloned plasmid was used for subcloning into pBM61. The cloned plasmid was 
digested with EcoRI to get the insert, it was ligated with pBM61 plasmid digested with 
EcoRI, and transformed into DH5 alpha chemical competent cells. Many colonies were 
seen in experimental plates and they were picked and DNA tested using BamHI, HindIII 
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and EcoRI (Fig.3.31, 3.32, 3.33 respectively). As can be seen there were some colonies 
(number 1-5) with the expected size. Correct cloning was confirmed by sequencing the 
plasmid and colony 3 was chosen for complementation. 
 
 
Fig 3.20. pBM61 his-3 targeting plasmid. Adapted from www.fgsc.net. 
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Table 3.9. Cloning trials with different enzymes. 
 
 
Fig 3.21. Integration of pBM61 plasmid and insert and reconstitution of his-3+ 
genotype. 
 
166 bp upstream F-1  5'  AATT GAATTC ATCCGCATCTCACATCCACTAGC  3'
104 bp downstream R-2  5'  CTCATCGACGTGAAACCTACAGC  3'
1 kb upstream NotI F-1  5'  ATAAGAAT GCGGCCGC ACATGGAAGTGGTGGTTTGT  3'
1 kb downstream Apa I R-1  5' TCC GGGCCC AACAAATATTAACGAGAATCTTCA  3'
202 bp upstream BsaBI F-1   5'  TCC GATGTATATC GGTCTGGCACAGGATCCGCATCTC  3'
500 bp downstream ApaI R-1   5'  TCC GGGCCC AAATCAACACCGGAATCATAAGAC  3'
1 kb upstream BsaBI F-1   5'  TCC GATGTATATC ACATGGAAGTGGTGGTTTGTGTTG  3'
976 bp downstream ApaI R- 1  5'  TCC GGGCCC AACAAATATTAACGAGAATCTTCA  3'
10601 bp
12328 bp
11899 bp
Insert Size
3920
5605
4351
5649
Up and downstream of gene Restriction Enzyme Forward and reverse primers
Size of 
plasmid and insert
EcoRI 10971 bp
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Fig 3.22. Digestions of plasmid and insert with NotI and ApaI restriction enzymes 
shown with 1kb ladder. 
1. Uncut plasmid  
2. Plasmid digested by NotI 
3. Plasmid double digested by NotI and ApaI 
4. Insert digested by NotI 
5. Insert double digested by NotI and ApaI 
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Fig 3.23. Short and long construct PCR products for cloning using BsaBI and 
ApaI. The first bands (short construct: ~ 4 kb and long construct ~ 5.5 kb) are inserts. 
The other bands are non-specific.  
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Fig 3.24. Digestion of insert and plasmid by BsaBI and ApaI. Marked bands with 
yellow rectangle are the correct bands. 
1. Large PCR double digest (first band is the correct band) 
2. Small PCR first digest  
3. Small PCR double digest (first band is the correct band) 
4. Large PCR first digest 
5. Plasmid double digest (first band is the correct band) 
6. Plasmid first digest 
7. Plasmid double digest (first band is the correct band) 
8. Uncut plasmid 
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Fig.3.25. Cloning with EcoRI. Colonies were picked and plasmids were digested by 
EcoRI on the left picture (2 bands expected) and BamHI on the right picture (3 bands 
expected). 
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Fig 3.26. pSTblue-1 plasmid. Adopted from Novagen website 
(http://www.emdmillipore.ca). 
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Fig 3.27. Digestion of colonies picked from the first trial of PSTblue cloning by 
HindIII (two bands of ~6kb and ~2.5 kb were expected). 
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Fig 3.28. Digestion of colonies picked form the first trial of PSTblue cloning by 
BamHI (four bands were expected).  
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Fig 3.29. Digestion of colonies picked from the second trial of PSTblue cloning by 
BamHI 
 
 
Fig 3.30. Digestion of colonies #10 and #16 picked from cloning 2 by HindIII 
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Fig 3.31. Colonies picked from sub-cloning to pBM61 digested by BamHI. 3 
bands of 7.3 kb, 2.3 kb and 1.3 kb were expected. Colonies number 1, 2, 3, 4 and 5 
show the expected sizes. 
 
 
Fig 3.32. Colonies picked from sub-cloning to pBM61 digested by HindIII. 3 
bands of 5.2 kb, 4 kb and 1.7 kb were expected. Colonies number 1, 2, 3, 4, 5 and 6 
show the expected sizes. Colonies 7 and 8 do not look as predicted. 
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Fig 3.33.Colonies picked from sub-cloning to pBM61 digested by EcoR1. 2 bands 
of 7 kb and 4 kb were expected. All the colonies show the predicted size except 
colonies number 7 and 9. 
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3.5. Complementation 
After cloning the gene into the his-3 targeting plasmid, the plasmid was transformed 
into fungal spores. For complementation, strain SG#310 (bd csp-1 chol-1 his-3 prd-1) 
was used. Fresh spores were harvested and in the first trial they were suspended in 40 ul 
of sorbitol. The spore suspension was too viscous and transformation failed. In the second 
trial spores were suspended in 2ml of sorbitol and transformation was successful. After 
electroporation they were plated and after 3 days 33 colonies were picked and grown on 
choline media. All of the colonies grew on choline media and all of 33 transformants 
were placed on race tubes to check the growth rate and period compared to SG#26 (bd 
csp-1) and SG#260 (bd csp-1 prd-1).  
The results from race tubes showed that transformants were complemented and 
showed growth rate and period similar to wild type (Fig.3.34 and Table 3.10). Because 
the transformed macroconidia may have two or three nuclei, the transformants may be 
heterokaryons with both his-3 and his+ nuclei. Therefore, microconidia were made to 
purify single nuclei from strains 29, 4, 14, 34 and 22. In order to make microconidia, a 
medium that induces stress, prevents the fungus from making aerial hyphae and forces 
the fungus to make microconidia that have single nuclei was used. Microconidia were 
plated and colonies were picked for each strain. The growth rates and periods of 
microconidia colonies growing on race tubes are shown in Figure 3.35 and Table 3.11. 
To check the transformation, DNA from these transformants was extracted. Primers 
were designed to amplify the fusion between the insert and the his-3 downstream 
insertion site (Fig. 3.36) and PCR was done with DNA from the original transformants. 
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The expected bands were ~1.5kb and could be seen on the gel (Fig.3.37) which means 
that transformation was successful. This result indicates that the prd-1 gene is identified 
as an RNA helicase that is including a DEAD box domain and helicase domain. 
 
 
Fig 3.34. prd-1 transformants phenotype 
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Table 3.10. Growth rate and period of transformants after complementation. Two 
or three replicate race tubes were grown for each strain. For colonies # 4, 29 and 22 
only one of the tubes showed bands and the growth rate was slow so they were not 
complemented. 
 
 
Fig 3.35. Phenotypes of prd-1 microconidia colonies. 
 
Strain Number Growth Rate Period G.R Average Pr. Average
1.34 22.54
1.34 22.55
1.32 21.73
0.78 24.77
0.80 24.48
0.76 24.61
1.36 21.33
1.26 22.85
1.27 22.56
1.20 24.47
1.26 20.14
0.45
1.20 23.21
0.53
1.35 22.77
0.88
SG#260(bd,csp-1,prd-1)
1.23
1.26
Colony#29
Colony#22
0.78 24.62
23.21
22.77
1.20
1.35
22.27
22.09
23.51
20.14
SG#26(bd,csp-1)
Colony#34
Colony#14
Colony#4
1.33
1.31
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Table 3.11. Average of growth rate and period of microconida colonies compared 
to w.t and mutant strains. 
 
 
Fig 3.36. Designing the fusion primers. Fusion primers were designed (F-1 and R-1 
are in the his-3 downstream sequence) to check if the insert is in the right place. 
 
Strains Period (h) Growth Rate (mm/h)
w.t 21.59 1.27
prd-1 chol-1 25 0.74
Transformant 1
(from # 4)
21.49 1.22
Transformant 2
(from #34)
22.83 1.19
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Fig 3.37. PCR with fusion primers of transformant DNA.  
Top lanes are primers F-10 and R-1, bottom lanes are primers F-1 and R-3. 
Number 4, 14 and 22 showed the expected size. 
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3.6. Effect of prd-6 on FLO 
As mentioned in the introduction, five prd mutations affect the period length of the 
conidiation rhythm. From the experiments of Li et al. (2010) it was shown that prd-1 and 
prd-2 genes are important components of FLO.  The prd-6 gene was also shown to be 
involved in FLO by adding geraniol or farnesol to the media (Lombardi et al. 2007) and it 
has the role of an RNA helicase. Because I have identified prd-1 as an RNA helicase, I 
wanted to see if other helicases are involved in FLO. In order to check if prd-6 also 
affects the FLO in our lab assay, which is low and high choline concentration media, a 
cross between SG#127 (bd csp-1 chol-1 frq9) and FGSC#11230 (prd-6 ko) was set up to 
construct chol-1 prd-6 double mutants. 
187 spores were picked and were checked for csp+ and csp-1 by tapping the baby 
tubes:  the ones with flying spores are csp+, however progeny with clumpy spores are 
csp-1. 63 csp-1 progeny were tested on race tubes (with minimal and choline media) The 
growth rate and period were calculated by Mac Tau software. Chol-1 progeny grow 
slowly on minimal medium.  Progeny that are bd show bands in race tubes and bd+ 
progeny show fast growth rate and no bands. In frq9 progeny, mycelia are fluffy and do 
not show any bands. Progeny were also tested for hygromycin resistance; the hygr 
progeny have the prd-6 knockout parent (the knockout gene is replaced by the hph 
cassette which confers hygromycin resistance) (Colot et al., 2006). 
Results of race tubes are shown in Table 3.12. In order to get better results this 
experiment was repeated with more replicates. I repeated the race tubes for three progeny 
of each genotype, and for each strain five tubes of minimal and five tubes of choline 
media were used. The summary of results is shown in table 3.13. For statistical test, all 15 
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replicates of one genotype were pooled. A t-test between frq9 prd+ and frq9 prd-6 was 
calculated for growth rate in minimal media (p-value = 2.18*10-6, t =6, df = 11) and for 
growth rate in choline media (p-value = 2.22*10-9, t = 2.69, df = 11) and shows that the 
growth rates are significantly different. Periods in minimal media are not different (p = 
0.39, t = 0.76, df = 11). A t-test between frq+ prd+ and frq+ prd-6 shows that in choline 
media growth rate and period are significantly different and period is shorter in prd-6 
strains (p = 2.37*10-8, t = 7.95, df = 11 and p = 1.56*10-8, t = 7.2, df = 11 respectively). 
In minimal media growth rate is not significantly different however period is significantly 
different (p = 0.55, t = 0.5, df = 11 and p = 6.71*10-5, t = 4.18, df = 11 respectively). It 
can be concluded that prd-6 has an effect on FLO and lengthens the period but to confirm 
this conclusion more repetition of experiments needs to be done.   
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Table 3.12. Strains from cross between SG#127 and FGSC# 1123 
 
Growth R. Period Growth R. Period
#13 0.49 65.95 1.22 0
#22 0.5 81.17 1.19 0
#28 0.45 93.27 1.22 0
#10 0.54 50.96 1.29 0
#11 0.72 54.8 1.12 0
#17 0.7 70.95 1.08 0
#1 0.6 81.79 1.06 0
#21 0.63 81.87 1.09 0
#46 0.56 98.12 1.01 0
#31 0.64 75.57 1.31 0
#25 0.53 0 1.17 25.13
#48 0.59 0 1.18 25.54
#61 0.65 0 1.28 25.42
#56 0.51 65.88 1.25 24.3
#30 0.65 0 1.12 25.74
#35 0.42 78.2 0.88 25.65
#4 0.47 77.3 0.97 19.15
#43 0.48 80.29 0.89 19.23
#47 0.52 72.14 0.97 21.88
#58 0.53 65.98 1.07 19.44
#38 0.51 78.45 1.02 19.92
#32 0.44 51.23 0.72 22.74
#63 0.54 55.75 0.89 21.43
bd csp-1 SG#1 1.51 20.51 1.46 19.28
bd csp-1 chol-1 frq9 SG#127 0.44 86.93 1.55 38.41
bd csp-1 chol-1 SG#26 0.47 76.39 1.44 19.32
Strain#
minimal choline
bd csp-1 chol-1 frq9 prd-6+
bd csp-1 chol-1 frq9 prd-6
bd csp-1 chol-1 frq+ prd+
bd csp-1 chol-1 frq+ prd-6
Genotye
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Table 3.13. Summary of more replications of prd-6 experiment. Mean and SEM of 
each group were calculated. 
 
3.7. Is prd-2 an RNA helicase? 
According to data from prd-2 mapping from our lab (prd-2 has not been identified 
yet), there were no recombinants between the markers that were used in mapping and a 
region containing the gene NCU01143 known as msp-8, an RNA helicase. We 
hypothesized that msp-8 could be prd-2 and can interact with other helicases such as prd-
1 and prd-6, so it was decided to sequence the gene. In order to sequence the msp-8 gene, 
I extracted DNA from SG#171 (bd prd-2) for PCR. Primer F-1 and R-1 were used for 
PCR (table 3.14). Thirteen forward and six reverse primers were designed to cover 519 
bp upstream and 607 bp downstream of the gene. Sequencing was repeated for some 
regions but I didn’t find any mutation in this gene, therefore it can be concluded that msp-
8 is not prd-2.  
Period G.R Period G.R
#10 55.46± 4.1 0.56± 0.01 0.00 1.56± 0.04
#22 54.87± 2.4 0.57± 0.01 0.00 1.64± 0.09
#28 54.80± 1.7 0.53± 0.009 0.00 1.74± 0.07
#61 51.84± 3.13 0.50± 0.02 21.15± 0.32 1.54± 0.07
#56 61.01± 4.36 0.50± 0.03 21.14± 0.17 1.76±0.08
#25 54.31± 6.7 0.57± 0.03 21.31± 0.37 1.57± 0.03
#17 51.79± 1.5 0.63± 0.01 0.00 1.27± 0.01
#21 44.92± 4.2 0.74± 0.04 0.00 1.26± 0.009
#46 60.51± 4.4 0.74± 0.03 0.00 1.15± 0.03
#58 74.75± 4.5 0.53± 0.01 17.04± 0.07 1.25± 0.01
#43 77.90± 1.7 0.47± 0.01 18.54± 1.15 1.13± 0.03
#47 65.31± 2.66 0.54± 0.01 16.5± 0.6 1.32± 0.01
bd csp-1 chol-1 SG#26 55.48± 3.6 0.52± 0.02 21.32± 0.1 1.42± 0.02
bd csp-1 chol-1 frq9 SG#127 59.33± 3.2 0.52± 0.03 0.00 1.68± 0.02
Minimal Choline
Progeny #Genotype
bd csp-1 chol-1 frq9 prd+
bd csp-1 chol-1 frq+ prd+
bd csp-1 chol-1 frq9 prd-6
bd csp-1 chol-1 frq+ prd-6
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However, if RNA helicases are important in the FLO, msp-8 could have an effect on 
FLO. Therefore based on this hypothesis a cross between SG#127 (bd csp-1 chol-1 frq9) 
and FGSC#12359 (msp-8 ko) was set up. From the cross 167 spores were picked, 61 csp-1 
progeny were tested in race tubes on minimal and choline media, 33 chol-1 progeny were 
collected and the growth rate and period were calculated by Mac Tau software. 
Genotypes for csp-1, bd, chol-1 and frq9 were determined as for the prd-6 cross. Progeny 
were also tested for hygromycin resistance; the hygr progeny have msp-8 knockout. The 
preliminary results are shown in table 3.14, but to get more reliable results the experiment 
was repeated using a few progeny with more replications.  
From results presented in Table 3.15, and t-test between frq+ msp+ and frq+ msp-8 it 
can be concluded that there is no significant difference in growth rate on minimal media 
(p = 0.3, t = 0.8, df = 11). There is no difference in growth rate and period in choline 
media (p = 0.5, t = 0.51, df = 11 and p = 0.3, t = 0.8, df = 11 respectively). T-test between 
frq9 msp+ and frq9 msp-8 shows that there is a significant difference in growth rate in 
minimal media (p = 0.006, t = 3, df = 11) but there is no difference in choline media (p = 
0.24, t = 1.29, df = 6). Msp-8 strains were arrhythmic on minimal unlike msp+. Therefore, 
Msp-8 may be one of the components of the FLO but further experiments are being done 
to confirm these results. 
 
 
 
100 
 
 
Table 3.14. Choline requiring progeny from the msp-8 cross. Growth rate and 
period are shown. 
 
Growth Rate Period Growth Rate Period
#35 0.38 0 1.11 24.76
#43 0.44 0 1.36 21.07
#44 0.39 0 1.22 22.04
#48 0.27 106.23 1.07 19.92
#51 0.35 0 1.36 22.05
#54 0.4 0 1.46 20.42
#65 0.41 0 1.36 20.79
#68 0.41 0 1.36 23.42
#1 0.35 0 1.35 0
#2 0.4 0 1.57 0
#5 0.39 0 1.58 0
#10 0.43 0 1.54 0
#11 0.4 75.68 1.52 0
#12 0.43 0 1.54 0
#26 0.4 0 1.54 0
#38 0.44 0 1.38 0
#31 0.38 0 1.36 21.27
#32 0.33 0 1.29 21.99
#34 0.31 0 1.28 22.15
#40 0.42 0 1.47 21.35
#50 0.36 83.94 1.48 21.6
#4 0.39 0 1.58 0
#18 0.34 0 1.47 0
#19 0.36 0 1.53 0
#20 0.65 0 1.43 0
#22 0.39 0 1.46 0
#27 0.66 0 1.46 0
bd csp-1 SG#1 1.51 20.51 1.46 19.28
bd csp-1 chol-1 frq9 SG#127 0.44 86.93 1.55 38.41
bd csp-1 chol-1 SG#26 0.47 76.39 1.44 19.32
Minimal Choline
Genotype Strain #
bd csp-1 chol-1 frq+ msp-8+
bd csp-1 chol-1 frq9 msp-8+
bd csp-1 chol-1 frq+ msp-8
bd csp-1 chol-1 frq9 msp-8
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Table 3.15. Summary of more replications of msp-8 experiment. Mean and SEM 
of each group is shown. Five replicate tubes were averaged for each strain.   
Period G.R Period G.R
#48 59.25± 3.9 0.43± 0.02 20.52± 0.5 1.59± 0.006
#58 65.25± 6.1 0.43±  0.02 20.44±  0.2 1.47±  0.01
#43 65.37± 2.1 0.43±  0.01 21.17± 0.4 1.43±  0.02
#11 60.85± 5.2 0.45 ±0.01 0.00 1.56± 0.01
#12 62.74± 3.07 0.45±0.008 0.00 1.54± 0.02
#26 56.92± 7.8 0.46± 0.008 0.00 1.48±0.05
#50 0.00 0.38± 0.01 20.9± 0.2 1.39±  0.02
#51 0.00 0.33±  0.008 21.15±  0.24 1.44±  0.06
#40 0.00 0.51±0.027 20.79± 0.18 1.59± 0.03
#4 0.00 0.4± 0 0.00 1.55± 0.02
#18 0.00 0.43± 0.02 0.00 1.61± 0.03
#22 0.00 0.42± 0.02 0.00 1.5± 0.04
bd csp-1 chol-1 SG#26 56.96±  3.08 0.52±  0.01 20.42±  0.2 1.45±  0.01
bd csp-1 chol-1 frq9 SG#127 62.29±  1.65 0.45± 0.01 0.00 1.55±  0.007
bd csp-1 chol-1 frq9
bd csp-1 chol-1 msp-8
bd csp-1 chol-1 msp-8 frq9
Minimal Choline
Progeny #Genotype
bd csp-1 chol-1
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4. Discussion  
4.1. Gene identification 
 The purpose of this thesis was to finish mapping the prd-1 gene and identify the 
gene. CAPS markers were used to identify a narrow interval containing the gene. The 
mapping was continued by sequencing the genes in the narrowed interval and the 
mutation was found in one of the candidate genes. In order to identify the gene by 
complementing the mutation, the gene was cloned in the his-3 targeting plasmid and 
transformed into the his-3 prd-1 strain.  
After complementation of the prd-1 candidate gene, and rescue of the wild type 
phenotype (growth rate and period) it was confirmed that this gene (NCU07839) is prd-1. 
This gene is identified as an RNA helicase that contains a DEAD box domain and a 
helicase domain. The DEAD-box class of RNA helicases have fundamental roles in RNA 
and RNP structure in all the phases of RNA metabolism.  
4.2. Amino acid annotation 
The mutation is a substitution of G to A at the 5’ splice junction of one of the introns 
and cDNA alignments showed that this mutation changes the reading frame and can 
change the amino acid sequence of the protein produced. The wild type amino acid 
sequence shows that the protein contains a DEXDc domain (DEAD-like helicases 
superfamily) which is located from amino acid 151 to 354, and HELICc domain (helicase 
superfamily c-terminal domain) which is located from amino acid 395 to 476. There are 
also two low complexity regions at the beginning and the end of the protein. The region 
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starts at position 2 and ends at position 69, and position 519 and ends at position 551. 
Domains are shown in figure 4.1. 
 
 
Fig. 4.1. Domains of RNA helicase that are the DEAD-box domain and helicase 
domain and two low complexity regions. The protein sequence from Broad Institute 
Database was introduced into SMART website (smart.embl-heidelberg.de) to generate 
this schematic. 
 
The wild type amino acid sequence is shown in Figure 4.2. Different domains are 
shown by different colors. After changing the reading frame based on cDNA sequencing 
for the mutant, the stop codon was eliminated based on the alteration of the sequence (Fig 
4.3). By adding nucleotides downstream to find the stop codon the amino acid sequence 
of the mutant was predicted (Fig.4.4). Wild type protein has 563 amino acids and mutant 
protein has 611 amino acids. 
As can be seen this mutation does not have any effect on the DEAD-box domain or 
helicase domain but it changes the low complexity region at the C-terminus. This region 
is enriched by Glycine in wild type; however it is enriched in Valine in the mutant (Fig 
4.3 and 4.4). This mutation may have an effect on a binding site between this protein and 
other proteins. As can be seen in predicted tertiary structure of the wild type and mutant, 
in the mutant there is an extra turn in the last helix at the C-terminus (shown with a white 
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arrow) therefore there is a difference in arrangement and conformation of the wild type 
and mutant proteins (Fig 4.5).      
 
 
 
Fig. 4.2. Wild type amino acid sequence. Purple and green are low complexity 
regions; red is DEXDc domain and blue is HELICc domain. Every 10 amino acid is 
scaled by *. 
 
 
 
                                      *                                  *                                  *                                   *                                  *
1 MSGSYGGGGYGGRGGGGGGYSNGYDRNGGGYSNNYSSHGGSNGYGGGGGGYGGGG 55
                                      *                                  *                                  *                                   *                                  *
56 GGYGGGGYGGGGGGDRMSALGAGLQKQNWDMSALPKFEKSFYQEHPSVANRSPAE 110
                                      *                                  *                                  *                                   *                                  *
111 VDKFRADHSIAVFGNNVPKPVETFDEAGFPRYVMDEVKAQGFPAPTAIQSQGWPM 165
                                      *                                  *                                  *                                   *                                  *
166 ALSGRDVVGIAETGSGKTLTYCLPAIVHINAQPLLAPGDGPIVLILAPTRELAVQ 220
                                      *                                  *                                  *                                   *                                  *
221 IQQEISKFGKSSRIRNTCVYGGVPKGPQIRDLSRGVEVCIATPGRLIDMLESGKT 275
                                      *                                  *                                  *                                   *                                  *
276 NLRRVTYLVLDEADRMLDMGFEPQIRKIIGQIRPDRQTLMWSATWPKEVRNLAAD 330
                                      *                                  *                                  *                                   *                                  *
331 FLTDFIQVNIGSMDLAANHRITQIVEVVSESEKRDRMIKHLEKIMEGRENQNKIL 385
                                      *                                  *                                  *                                   *                                  *
386 IFTGTKRVADDITRFLRQDGWPALSIHGDKQQNERDWVLDQFKTGKSPIMVATDV 440
                                      *                                  *                                  *                                   *                                  *
441 ASRGIDVRNITHVLNYDYPNNSEDYIHRIGRTGRAGAKGTAITFFTTDNSKQARE 495
                                      *                                  *                                  *                                   *                                  *
496 LVGVLQEAKQQIDPRLAEMARYSGGGGGRFGGYRGRGGGGWRGGRGGGGGGGSVG 550
                                      *                                  *                                  *                                   *                                  *
551  GANALPLNNRRW* 562
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Fig 4.3. Mutant amino acid sequence without stop codon. Purple and green are low 
complexity regions; red is DEXDc domain and blue is HELICc domain. From amino 
acid 489 the sequence is different in wild type and mutant. Every 10 amino acid is 
scaled by *. 
 
 
                                      *                                  *                                  *                                   *                                  *
1 MSGSYGGGGYGGRGGGGGGYSNGYDRNGGGYSNNYSSHGGSNGYGGGGGGYGGGG 55
                                      *                                  *                                  *                                   *                                  *
56 GGYGGGGYGGGGGGDRMSALGAGLQKQNWDMSALPKFEKSFYQEHPSVANRSPAE 110
                                      *                                  *                                  *                                   *                                  *
111 VDKFRADHSIAVFGNNVPKPVETFDEAGFPRYVMDEVKAQGFPAPTAIQSQGWPM 165
                                      *                                  *                                  *                                   *                                  *
166 ALSGRDVVGIAETGSGKTLTYCLPAIVHINAQPLLAPGDGPIVLILAPTRELAVQ 220
                                      *                                  *                                  *                                   *                                  *
221 IQQEISKFGKSSRIRNTCVYGGVPKGPQIRDLSRGVEVCIATPGRLIDMLESGKT 275
                                      *                                  *                                  *                                   *                                  *
276 NLRRVTYLVLDEADRMLDMGFEPQIRKIIGQIRPDRQTLMWSATWPKEVRNLAAD 330
                                      *                                  *                                  *                                   *                                  *
331 FLTDFIQVNIGSMDLAANHRITQIVEVVSESEKRDRMIKHLEKIMEGRENQNKIL 385
                                      *                                  *                                  *                                   *                                  *
386 IFTGTKRVADDITRFLRQDGWPALSIHGDKQQNERDWVLDQFKTGKSPIMVATDV 440
                                      *                                  *                                  *                                   *                                  *
441 ASRGIDVRNITHVLNYDYPNNSEDYIHRIGRTGRAGAKGTAITFFTTDKTPSRLV 495
                                      *                                  *                                  *                                   *                                  *
496 SSSVCFKKLSSRLTLDLPRWLATVVVEVAASVAIAAVAAVDGAVAVAAVVAAAPS 550
                                      *                                  *                                  *                                   *                                  *
551  VVLMLFRLTTAGG 563
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Fig 4.4. Mutant amino acid sequence with stop codon (mutation makes the protein 
larger than wild type). Every 10 amino acid is scaled by *. 
 
 
 
 
 
 
 
 
                                      *                                  *                                  *                                   *                                  *
1 MSGSYGGGGYGGRGGGGGGYSNGYDRNGGGYSNNYSSHGGSNGYGGGGGGYGGGG 55
                                      *                                  *                                  *                                   *                                  *
56 GGYGGGGYGGGGGGDRMSALGAGLQKQNWDMSALPKFEKSFYQEHPSVANRSPAE 110
                                      *                                  *                                  *                                   *                                  *
111 VDKFRADHSIAVFGNNVPKPVETFDEAGFPRYVMDEVKAQGFPAPTAIQSQGWPM 165
                                      *                                  *                                  *                                   *                                  *
166 ALSGRDVVGIAETGSGKTLTYCLPAIVHINAQPLLAPGDGPIVLILAPTRELAVQ 220
                                      *                                  *                                  *                                   *                                  *
221 IQQEISKFGKSSRIRNTCVYGGVPKGPQIRDLSRGVEVCIATPGRLIDMLESGKT 275
                                      *                                  *                                  *                                   *                                  *
276 NLRRVTYLVLDEADRMLDMGFEPQIRKIIGQIRPDRQTLMWSATWPKEVRNLAAD 330
                                      *                                  *                                  *                                   *                                  *
331 FLTDFIQVNIGSMDLAANHRITQIVEVVSESEKRDRMIKHLEKIMEGRENQNKIL 385
                                      *                                  *                                  *                                   *                                  *
386 IFTGTKRVADDITRFLRQDGWPALSIHGDKQQNERDWVLDQFKTGKSPIMVATDV 440
                                      *                                  *                                  *                                   *                                  *
441 ASRGIDVRNITHVLNYDYPNNSEDYIHRIGRTGRAGAKGTAITFFTTDKTPSRLV 495
                                      *                                  *                                  *                                   *                                  *
496 SSSVCFKKLSSRLTLDLPRWLATVVVEVAASVAIAAVAAVDGAVAVAAVVAAAPS 550
                                      *                                  *                                  *                                   *                                  *
551 VVLMLFRLTTAGGKAPLEANQHISIDLPGPIHCRHGHSTRRMAHYSDNFDLEHDH 603
                                      *                                  *                                  *                                   *                                  *
604  GVLVEDTV* 611
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Fig 4.5. Wild type (left panels) and mutant (right panels) predicted tertiary structure 
from Phyre website (http://www.sbg.bio.ic.ac.uk/phyre2/html/page.cgi?id=index). 
White arrow shows the difference between wild type and mutant.  
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4.3. DEAD-box RNA helicases 
While RNA is known for being single stranded, more often than not it has the 
tendency to fold on itself and form intramolecular helices important for RNA molecule 
function. The efficient binding and interaction of RNA with RNA-binding proteins is 
almost entirely dependent on the RNA folding (Zemora and Waldsich 2010; Woodson 
2010). One class of enzymes that control and regulate cellular RNA structure are 
DEAD-box RNA helicases. These helicases belong to one of the largest classes of the 
RNA helicase superfamily. DEAD-box proteins have a wide range of functions some 
of which include: duplex unwinding, ATPase activity, displacement of RNA-binding 
protein from single-stranded RNA, RNA strand annealing, and acting as a platform for 
larger ribonucleoprotein complexes.  Despite being classically defined as helicase 
enzymes, DEAD-box proteins can also function as RNA chaperones, and are involved 
in numerous biochemical processes to form and assemble RNPs. 
DEAD-box helicases share the highly conserved SF2 helicase core that contains 
two nearly equal domains (Fig. 4.6), with each domain bearing similarity to the 
recombination protein RecA. The C- and N-terminal domains of DEAD-box helicases 
are often not conserved. Two helicase domains are connected with a flexible linker, 
allowing it to change orientation. This is particularly important as it facilitates the 
opening and closing of these two domains, which are essential for the function of the 
enzyme. For instance when the core domains are closed, the enzyme can have an 
ATPase function (Linder et al. 2011). The name DEAD box for this family is given 
because of motif II that contains the Asp-Glu-Ala-Asp motif. 
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Fig 4.6.  A) The primary structure of DEAD-box RNA helicase. Domain 1 (N-
terminus) is shown in brown and domain 2 (C-terminus) is shown in blue. Different 
motifs are shown and color-coded based on their activity (blue is RNA binding, red is 
ATP binding and green is coordination between ATP and RNA binding). Circled 
numbers show the location of the sequenced motifs. B) The conserved sequences of 
motifs of DEAD-box helicases are shown. Amino acid conservation is represented by 
the height of the letter. C) Tertiary structure of two RecA like domains is shown, β-
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strands are indicated by arrows, α-helices are indicated by cylinders. (Adapted from 
Putnam and Jankowsky 2013) 
 
4.4. DEAD-box RNA helicase roles in the cell 
4.4.1. The basic biochemical features 
RNA binding and coupling to ATP binding:  RNA is bound by the helicase core 
of probably all DEAD-box proteins through a set of conserved residues in motifs Ia, b, 
c and motifs IV, IVa, V, and Va (Fig.4.6). Mallam and colleagues (2012) have shown 
that single stranded RNA can bind to both helicase domains; they further conclude that 
in this way RNA stimulates the formation of the closed state of these domains thereby 
forming the active site for ATP hydrolysis. It is worth mentioning that RNA duplex can 
only bind to domain 2 (Mallam et al. 2012).  
Nucleotide binding and metabolite sensing: According to Parvatiya and 
colleagues (2012) some DEAD-box helicases can bind other adenine-based and related 
nucleotides (i.e. AMP). In the case of these helicases, AMP binds exclusively to ATP 
binding residues in the helicase domain 1 (Hogbom et al. 2007). It is also known that 
DDX41 binds to cyclic di-GMP (c-di-GMP) and cyclic di-AMP (c-di-AMP) but it is 
not known whether they bind like ATP or ADP. Consequently, it can be concluded that 
DEAD-box helicases could play a role in providing energy for RNA metabolism in 
response to metabolic stresses that increase AMP levels (Parvatiyar et al. 2012) 
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Protein binding: Like most other enzymes, DEAD-box helicases require other 
proteins to carry out their functions. Such proteins bind a DEAD-box helicase at the 
auxiliary and core domains of the enzyme (Linder et al. 2011). 
 
Oligomerization and posttranslational modifications: RNA, nucleotide and 
protein binding of DEAD-box helicases depends on the oligomeric state of the DEAD-
box helicase, and its post-translational modifications define how RNA, nucleotides, 
and proteins bind the helicase. DEAD-box helicases can be functional in oligomeric, 
dimeric or even monomeric states. The post-translational modifications of DEAD-
boxes include: phosphorylation, methylation, and sumo modification (Jacobs et al. 
2007).  
4.4.2. RNA-related activities of DEAD-box helicases 
RNA-stimulated ATPase activity:  DEAD-box helicases are often referred to as 
RNA dependent ATPases, as they are all capable of hydrolyzing ATP in the presence 
of RNA (Parvatiyar et al. 2012). 
RNA unwinding:  The ATP driven unwinding of RNA, requires coordination 
between ATP and RNA binding. RNA unwinding is associated with conformational 
changes of the enzyme (Jarmoskaite et al. 2011). Mutations in DEAD-box proteins can 
impair unwinding the RNA duplexes, therefore impairing cellular functions. 
RNA clamping: RNA clamping refers to the capacity of a DEAD-box helicase to 
remain bound to RNA for a longer period of time. Therefore, it can make a platform for 
larger complexes. 
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Protein displacement: Remodeling of RNA–protein complexes (RNPs) by 
displacement of proteins is thought to be a main function of DEAD-box and other 
helicases. Thus it can help to unwind the duplex RNA. 
Strand annealing: Several DEAD-box helicases are known to promote the 
formation of duplex structure. Strand annealing does not require ATP or ADP.  Mallam 
et al. (2012) have shown that that DEAD-box helicases bind to a duplex in domain 2. It 
was proposed that the ability to promote duplex formation can be related to other 
aspects of the enzyme’s function as RNA chaperones (Jarmoskaite et al. 2011). 
RNA structure conversion: DEAD-box helicases have the function of converting 
one RNA structure to another. This function is also known as RNA chaperones.  
 
4.5. RNA helicases and regulation of circadian rhythms in Neurospora 
FRQ-interacting RNA helicase (FRH) is a member of the SK12 subfamily of RNA 
helicases, and an important DEAD box-containing RNA helicase in Neurospora. FRH 
contains a DEAD/DEAH box and helicase C domains. It makes a complex with FRQ 
(FFC) and is known as an important clock component. Chang et al. (2005) have used 
frh specific dsRNA that downregulates frh expression, to show that a complex of FRQ-
FRH plays an important role in sustaining the steady level of FRQ. 
When FRH is downregulated levels of FRQ reduce and levels of frq RNA increase, 
this can impair the negative feedback loop. Moreover, it is known that FRH moderates 
the interaction between FRQ and WC complexes. FRQ-FRH interaction is important 
for FRQ-WC interactions because once the former interaction is disrupted, the latter 
interaction will be eliminated (Cheng et al. 2005). 
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Dob1p/Mtr4p is known to be a homolog for FRH in yeast. Dob1p/Mtr4p is a RNA 
helicase that is the main component of the exosome complex and acts as a cofactor for 
the exosome to degrade or process RNA. (Liang et al. 1996; de la Cruz et al. 1998; 
Jacobs et al. 1998; Torchet et al. 2002). 
A study from Shi and colleagues (2010) has shown that a mutation in frh (frhR806H) 
can stop the rhythmicity but the interaction between FRQ and FRH remained intact 
indicating that FRQ-FRH interaction with WCC is disturbed. In the mutant strain 
phosphorylation of WC-1 is reduced and WC-1 stays hypophosphorylated. 
Overexpression of FRH leads to accumulation of WC-1 indicating that FRQ-FRH is 
important in WC-1 stability. In the FRH protein that has 1107 amino acids, the 
DEAD/DEAH domain is located in the N-terminal region and the helicase domain is 
placed in the middle of the protein. The R806H mutation was created close to the C-
terminal DSHCT domain. The functional domains for RNA helicase stay intact in this 
mutant, therefore the interaction of FRH and FRQ was not disrupted. However, it was 
speculated in this study that this mutation impairs the binding region of WCC.  This 
study showed that although FRH is essential and functional in the exosome, it has a 
specific role in clock-related responses (Shi et al. 2010). 
4.6. Other DEAD-box helicases and RNA-binding proteins that are 
involved in circadian rhythms 
Recently it was reported that RNA helicases DDX5 (DEAD-box polypeptide 5) and 
DHX9 (DEAH-box protein 9) are components of mouse PER complexes.  
Padamanbhan et al. (2012) showed that knockdown of DDX5 and DHX9 can lead to 
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increasing the per1 gene transcription and can alter the period. Moreover, FRH in 
Neurospora is related to DDX5 and DHX9.  
Mouse LARK protein (mLARK) is an RNA-binding protein that binds to the 3’ 
UTR of per1 and upregulates mPER1 protein expression. The homolog of mLARK in 
human, RNA-binding motif protein 4 (RBM4), has important roles in mRNA 
metabolism and translation control and alternative mRNA splicing. Knockdown of 
mLARK by siRNA resulted in shortening the period; however overexpression of 
mLARK lengthened the period. Thus, it is speculated that mLARKs have a role in 
mPER1 translation (Kojima et al. 2007). 
In Drosophila it was known that decreased or increased levels of lark resulted in 
early- or late pupa eclosion phenotypes, respectively (Newby and Jackson 1993). In a 
recent study in Drosophila, using RNAi to knockdown LARK and decrease its levels in 
clock neurons, it was shown that knockdown of LARK in clock neurons and also non-
clock cells resulted in arrythmicity in locomotor activity. This indicated that LARK is 
important for activity rhythms (Sundram et al. 2012). 
In Arabidopsis, a nuclear RNA-binding protein (AtGRP7) has been found as a 
component of the circadian clock system.This protein is an output that may regulate 
clock-controlled transcripts but it is not part of the oscillator. Its effect on translation 
has not been well studied (Heintzen et al. 1997). 
4.7. PRD-1 homolog 
Using a BLAST search the Prd-1 gene was found to be ortholog with Dbp2 
(Appendix-2). Cloutier et al. (2012) have demonstrated that DEAD-box protein Dbp2 
is associated with transcribing genes and has an important role in gene expression. 
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They have proposed that Dbp2 is a double- stranded RNA-specific ATPase that is 
required for accurate transcription and has a critical role in maintaining transcriptome 
and transcription fidelity (Cloutier et al. 2012). 
Cotranscriptional and posttranscriptional processes such as splicing, 3’ end 
cleavage and polyadenylation require proper nuclear mRNP assembly. Thus, mRNP 
must assemble with RNA-binding proteins to be involved in gene expression. It was 
shown that Dbp2 has a crucial role in mRNP assembly in the nucleus (Ma et al. 2013).  
The human ortholog of Dbp2, named p68, has been associated with many 
transcriptional and post-transcriptional processes like transcriptional regulation, 
alternative splicing, and microRNA processing (Janknecht 2010). These proteins are 
conserved in all eukaryotes.  
The prd-1 mutation is known to be not in the helicase and DEAD-box domain. The 
knockout for this gene does not exist in the stock centre indicating that the knockout of 
this gene should be lethal. Therefore, it can be said that PRD-1 protein is essential for 
Neurospora. 
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4.8. Future Directions 
Since this mutation is identified as an RNA helicase there are several questions that 
can be addressed.  
It is important to know what protein complexes are interacting with wild type that are 
absent or altered in PRD-1. In order to address this question an epitope tag can be used 
and after complementation and the phenotype verification, by immunoprecipitation and 
mass spectrometry the complex can be identified. After identifying the protein complex, 
mutations can be made in these genes or if the knockout is available it can be ordered 
from the stock centre, assaying the phenotype on race tubes can confirm their 
associations with FLO.  
Since the mutation does not have effects on helicase and DEAD-box domains it may 
have effects on binding sites with other complexes. Since the gene is an RNA helicase, it 
is important to know whether catalytic activity of PRD-1 is required for its function. To 
approach this question complementation with a construct that has a mutation in the 
catalytic domain, which can include mutation in the RNA binding and ATP hydrolysis 
domain, can be done. If the complementation fails, it means catalytic activity of PRD-1 
can regulate the circadian rhythm. Therefore it will be interesting to know what the RNA 
putative substrates are by RNA sequencing of immunoprecipitated PRD-1.   
As was mentioned PRD-1 is an important component of FLO and it is important to 
find out how the substrates (which are RNAs) are functional for the FRQ-less oscillator. 
It is critical to understand what these RNAs code for and what proteins are being 
regulated by this RNA helicase (like FRQ for FRH). After identifying transcripts, 
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knockouts for these genes can be used from the stock center and if they are not available 
in vitro mutagenesis can be done to check their phenotype in race tubes to see how 
important they are for FLO. 
PRD-6 is also identified as an RNA helicase, therefore there is a hypothesis that PRD-
1 and PRD-6 interact with each other or even with other PRDs. This can be tested by the 
immunoprecipitation methods described above. 
Another important question is whether the gene and protein expression are rhythmic 
for prd-1, which can be explored using northern and western blots respectively. Using the 
same technique the pattern of expression of WCC or FRQ will be studied in the prd-1 
mutant. 
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Appendix 
Appendix-1 
Media 
Liquid minimal medium (for microtiter wells or shaker flasks): 
2ml 50X Vogels 
2 g D-glucose  
100 ml water 
Minimal agar medium (for stock tubes and babies, 3 ml per tube or 1 ml per baby): 
2 ml 50X Vogels 
2 g D-glucose 
2 g agar 
100 ml water 
MA medium (maltose-argenine for race tubes, 6 ml per race tubes): 
2 ml 50X Vogels 
0.5 ml L-arginine, 20 mg/ml 
0.5 g maltose 
2 g agar 
100 ml water 
Growth supplements: 
Choline for stock tubes: 2 mg/ml, add 1.5 ml per 100 ml = 215 µM 
Histidine: 25 mg/ml, use 2 ml per 100 ml = 500 µg/ml 
Hygromycin: 50 mg/ml stock, use 0.4 ml per 100 ml = 200 µg/ml 
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50X Vogels stock medium: 
Add successively to 250 ml flask, stirring continuously: 
188 ml distilled water, stir and heat 
32.8 g Na3-citrate.2H2O, let it dissolve 
62.5 g KH2PO4 anhydrous, let dissolve 
25 g NH4NO3 anhydrous, let dissolve 
Turn off heat and add water to 250 ml. 
2.5 g MgSO4.7H2O, let dissolve 
1.25 g CaCl2.2H2O dissolved in 5 ml water 
1.25 ml trace elements solution 
0.625 ml biotin solution  
Allow to cool, add about 2 ml choloroform, cap tightly. Store at room temperature. 
Trace Elements: 
Add successively to 9.5 ml water, with stirring: 
0.5 g citric acid.H2O 
0.5 g ZnSO4.7H2O 
0.1 g Fe (NH4)2(SO4)2.6H2O 
0.025 g CuSO4.5H2O 
0.066 g MnSO4.4H2O 
0.005 g H3BO3 anhydrous 
0.0037 g (NH4)6MO7O24.4H2O 
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10X TAE Buffer: 
48.4 g Tris 
3.72 g EDTA disodium salt, dihydrate 
11.4 ml Acetic Acid 
~ 600 ml dH2O 
Measure out approximately 600 ml water in a beaker. Add one at a time of Tris, 
EDTA and Acetic Acid, stirring to dissolve completely after each. Adjust pH to 8.0. Pour 
into a graduated cylinder and add more water to equal 1 L total. 
DNA extraction Buffer: 
1.21 g Tris (final concentration 100mM) 
1.86 g EDTA (final concentration 50 mM) 
1 ml 10% SDS 
Dissolve Tris and EDTA with stirring in 80 ml dd H2O. Adjust PH to 8.0. Add water 
for a total volume of 100 ml. To make DNA extraction buffer wit 1% SDS, measure 1 ml 
10% SDS with 9 ml DNA extraction buffer. 
TE Buffer: 
0.121 g Tris (final concentration 10mM) 
0.0372 g EDTA (final concentration 1 mM) 
Dissolve Tris and EDTA with stirring in 80 ml dd H2O. Adjust pH to 8.0. Add water        
for a final volume of 100 ml. 
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LB Broth: 
Make 1 L, autoclave and use as required 
1% NaCl = 10 g 
0.5% Yeast Extract = 5 g 
1% Tryptone/peptone = 10 g 
Dissolve in 1L water and autoclave. 
 
LB agar plates: 
1% NaCl = 10 g 
0.5% Yeast Extract = 5 g 
1% Tryptone/peptone = 10 g 
1.5% agar = 15 g 
Dissolve frist three and add agar and autoclave. Cool it to 60oC in oven then add any 
antibiotics (if required). Add 1 ml ampicillin (1 ml/L) for 1000 ml LB agar. 
1X TSS: 
Make 50 ml LB broth at 2X concentration and autoclave: 
2% NaCl  
1% Yeast Extract  
2% Tryptone/peptone  
Add the following as power or from stock 
10 g Polyethylene Glycol as power 
5 ml DMSO 
0.5 ml of 1M stock to get a final concentration of 50 mM MgCl2  
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Make up the volume to final 100 ml; all this is in the sterile bottle 
Store at 4oC overnight before using the next day. 
Transformation of Neurospora: 
All the solution need to be sterile (autoclaved): 
1 M sorbitol 
9.1 g sorbitol, dissolved in about 30 ml water, then top up volume to 50 ml 
 
Recovery medium 
0.2 ml 50x Vogels 1.82 g sorbitol 9 ml water 
Choline (150 µl of 2 mg/ml) or any other supplement as needed (No histidine) 
Autoclave, allow to cool, add 1ml FIGS 
Plating media 
91 g sorbitol, dissolved in about 350 ml water, then add water to 450 ml total 
10 ml 50x Vogels 
Choline (7.5 ml of 2 mg/ml) or other supplement as needed (No histidine) 
14 g agar 
Autoclave, cool in oven to 50-60oC, add 50 ml FIGS 
FIGS 
10 g sorbose 
0.25 g fructose 
0.25 g glucose 
50 ml water 
Autoclave, cool to 50-60oC  
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100 ml flask medium for growing conidia: 
2 g glucose 
2g agar 
2 ml 50x Vogels 
2 ml histidine 25 mg/ml 
Plus any other supplement needed, such as choline (1.5 ml of 2 mg/ml) 
Dissolve in 100 ml water and autoclave. 
Microconida plating media: 
X SC (synthetic crossing medium) 
0.5% sucrose 
2% agar 
215 µM choline (if required) 
For 100 ml (5 plates): 
5 ml of 2X SC 
0.5 g sucrose 
2 g agar 
1.5 ml of 2 mg/ml stock  
100 ml water 
After autoclaving add 0.1 M stock filter- sterilized Na-iodoacetate.  
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Appendix-2 
Results of BLAST search using PRD-1 protein sequence 
(http://www.broadinstitute.org/annotation/genome/neurospora/GeneDetails.html?sp=S7000007580564890) 
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